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Research Experience for Undergraduates
University of Arkansas
The University of Arkansas Department of Chemistry and Biochemistry hosted a
National Science Foundation sponsored Research Experience for Undergraduates (REU) summer
program for the 20th year. The department first hosted an REU in 1959. The 10-week summer
program, funded by the National Science Foundation, allowed students an opportunity to gain
hands-on experience in a chosen research area while introducing them to careers in scientific
research in areas including analytical chemistry and sensor technology, biochemistry and protein
dynamics, inorganic chemistry and nanotechnology, organic chemistry, and physical and
theoretical chemistry.
Undergraduate chemistry majors, who were sophomores or juniors in fall 2007, applied
to the program, which took place in the Ozark Mountain Plateau.
Outside the lab, students met each week to hear presentations from campus experts about
topics ranging from how to get into graduate school and test-taking skills to ethics, and how to
make a poster presentation. A number of social activities took place throughout the summer to
give students a chance to interact.
Selected students received a scholarship to pay for room and board and an allowance to
attend a regional or national chemical conference in the 2008-2009 academic year. Students
involved in the program were enrolled as students at the U of A and received one hour of
research credit. The program was conducted from May 18, 2008 to July 25, 2008.
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Tony Jude Award
Kentucky native Nikita Patton, a student at Bennett College for Women, and Oregon
native Ivy Fitzgerald, a student at Agnes Scott College, were the recipients of the Tony Jude
Award for their summer research. The Tony Judy Award recognizes a student or students for
outstanding research. It is awarded in memory of a former REU student who returned to the
University of Arkansas and obtained a doctorate degree.
Nikita Patton, under the direction of Assistant Professor Paul Adams, presented a poster
entitled “Preliminary Characterization of the Binding of Peptide Derivative of an Important
RasGTPase Binding Effector for Abnormal Cell Signaling Mutants of the Ras Protein Cdc42.”
Ivy Fitzgerald, under the direction of Assistant Professor T.K.S. Kumar, presented a
poster entitled “Designing Fibroblast Growth Factor with Higher Heparin Binding Affinity.”
They are pictured below with Program Director Professor David Paul.
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REU Students 2008
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Faculty Project List
Paul Adams
Assistant Professor
Neil Allison
Associate Professor and ViceChair
Dan Davis
Professor
Bill Durham
Professor and Chair
Ingrid Fritsch
Professor
Bob Gawley
Distinguished Professor
Roger Koeppe
University Professor
T.K.S. Kumar
Assistant Professor
Matt McIntosh
Associate Professor
Frank Millett
Distinguished Professor
David Paul
Associate Professor
Xiaogang Peng
Associate Professor
Peter Pulay
Distinguished Professor
Josh Sakon
Associate Professor
Derek Sears
University Professor
Wesley Stites
Professor
Z. Ryan Tian
Assistant Professor
Charles Wilkins
Distinguished Professor
Jack Lay
Director, Statewide Mass
Spectrometry Facility

Biophysical characterization of proteins associated with signal
transduction
Organometallic chemistry, pentadienoyl chemistry, transition metal
metallacycles
Photosynthesis, biophysics
Photochemistry of metal complexes, electron transfer reactions of
metalloproteins
Miniaturized analytical devices, bioanalytical, electrochemistry,
surface modification, microfluidics
Organic chemistry – dynamics, structure, and reactivity of chiral
organometallics, sensor design, dendrimers, natural products
Membrane biophysics, voltage-dependent ion channels, design of
membrane-spanning peptides, protein engineering and drug design
Protein 3-D structure, dynamics, folding and interactions
Synthetic organic chemistry, natural products synthesis
Biological electron transfer, cytochromes, biophysics
Chemical sensors, instrumentation
Nano-technology, nano-crystalline materials
Ab initio methods, biophysics, parallel computing
Protein crystallography, biophysics
Cosmochemistry
Protein chemistry, protein folding, biophysics
Hierarchical and ordered nanostructures for catalytic, sensing, and
biomaterial applications
Fourier transform nuclear magnetic resonance, infrared, and mass
spectrometry, laboratory computer applications in chemical
instrumentation, fundamentals of gas phase ion-molecule reactions,
bioanalytical chemistry
Collaborates with other investigators that need mass spectrometry
measurements and develops new methods for analysis of chemical
and biologicals
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UNIVERSITY OF ARKANSAS
NSF – CHEMISTRY – REU - SUMMER 2008
Activities and Events
Sunday, May 18
2:00 p.m. – 4:00 p.m.
6:00 p.m. – 9:00 p.m.
Monday, May 19
8:00 a.m. – 8:45 a.m.

Arrival, Check-In & Registration

Maple Hill (front desk: (479)718-2590

Welcome Dinner
University House, Penguin Ed’s Barbeque
Breakfast
Quad Dinning Room

8:45 a.m.

Meet in quad lobby to go to university together

9:00 a.m. – 10:00 a.m.

Group Photo
Front of Library

10:00 a.m. – 12:00 p.m.

Campus Logistics (Concurrent Sessions)

RED
YELLOW

Session I: 10:00-10:50 a.m.
Session II: 10:00-10:50 a.m.

Session II: 11:00-11:50 a.m.
Session I: 11:00-11:50 a.m.

Session I:

Cash Checks, ID Cards Issued
Arkansas Union
Parking and Transit available: $15 per parking tag.
May park in lot 41 (near Reid Hall) Monday. Tag
needs to be displayed by Tuesday to avoid ticketing.
Session II: Library Orientation
University of Arkansas Mullins Library
12:00 p.m. - 1:30 p.m.

Opening Luncheon
Place: Student Union Ballroom
Speaker: Dr. Don Bobbitt, Dean, Fulbright College of Arts
and Sciences

1:30 p.m. – 2:30 p.m.

Campus Tour (Ending at Union)

2:30 p.m. – 4:30 p.m.

Departmental Logistics,
Place: Chemistry Building
Safety Briefing: Bill Durham, Department Chair
Meet your Mentor: Refreshments will be served
Get Keys, Take Photos
Leadership/Team Building Activity (Includes Lunch)

Tuesday, May 20
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9:00 a.m. – 3:00 p.m.

Graduate Education Building Auditorium, Room 166
Professor Ken Vickers
Balance of day free for logistics. Banking, Keys, etc.

3:00 p.m. – 4:00 p.m.

CHEMISTRY Library Tour
Place: CHEM 225
Librarian: Luti Salisbury

Wednesday, May 21
8:00 a.m.

Go to Your Lab and Get Started!

5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Reynolds Center, Seminar Room A
Speaker: Dr. Collis Geren, Dean of the Graduate School &
Vice Provost for Research
Topic: “Little Brown Spider”

Friday, May 23
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Dr. Don Bobbitt, Dean of the College of Arts &

Sciences

Topic: Ethics

Saturday, May 24 – Monday May 26 Free for Memorial Day Weekend
Wednesday, May 28
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Reynolds Center, Seminar Room A
Speaker: Panel of former REU students
Topic: Question/Answer session

Friday, May 30
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Dr. Paul Adams
Title: “New Strategies to Prevent Degradation of
Recombinant Proteins”

Wednesday, June 4
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Reynolds Center, Seminar Room A
Speaker: Dr. Robert Brady, Chair, Dept. of

Communications

Topic: Presentation Skills

Thursday, June 5
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: Chemistry

Friday, June 6

REU Meeting
6

1:00 p.m.

CHEM 105
Speaker: Dr. Lothar Schäfer
Title: “In Search of Divine Reality”

Wednesday, June 11
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Reynolds Center, Seminar Room A
Speaker: Dr. Dennis Brewer, Assoc. Vice Provost, Grad.

School

Topic: Research and Ethics

Thursday, June 12
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: Physics
Location:

Friday, June 13
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Dr. Julie Stenken
Title: “Microdialysis Sampling of Proteins Involved with
Chemical Communication”

Monday, June 16

Canoe Trip

Wednesday, June 18
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Reynolds Center, Seminar Room A
Speaker: Shani Farr, Graduate Recruiter
Topic: Applying to Graduate School

Thursday, June 19
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: microEP
Location: Veteran’s Park, Lake Fayetteville

Friday, June 20
1:00 p.m.

REU Meeting
CHEM 105
Half-way Progress Reports Due

Saturday, June 21
10 a.m.

Practice GRE and GMAT test offered
Testing is FREE
Participation requires pre-registration
Location: Bell Engineering, Room TBA

Thursday, June 26
6:00 p.m.- 9:00 p.m.

Evening Entertainment
Host: Mechanical Engineering
Location:
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Friday, June 27
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Liz Williams
Topic: Applying to Chemistry Graduate School

Thursday, July 3
6:00 p.m.- 9:00 p.m.

Evening Entertainment
Host: Carver
Location:

Friday, July 4 – Sunday, July 6 Free for Independence Day Weekend
You must return to Fayetteville by 8:00 a.m., July 7
Monday, July 7- 8
1.5 Days

Road Trip, National Lab

Wednesday, July 9
3:00p.m. – 7:00 p.m.

Final Carver Presentations

Friday, July 11
1:00 p.m.

REU Meeting
Chem 105
How to Make a Poster
Jennifer Sims, Editor, Chemistry and Biochemistry

Friday, July 18
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Dr. Bob Gawley
Title: “Why did Alice say to Kitty: Do you Suppose Looking
Glass Milk is Good to Drink?”

Thursday, July 24
10:00 a.m.

Meeting in Miniature, Lunch Served
CHEM 105

Friday, July 25
5:00 p.m.

End of Program
Final reports due
Dorm check-out

Saturday, July 26
By 11:00 a.m.

End of Program
Get out of the Dorm, last check-out
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Designing Fibroblast Growth Factor with Higher Heparin Binding Affinity
Ivy Fitzgerald, Agnes Scott College
Decatur, Georgia

Abstract
Fibroblast Growth Factors (FGFs) belong to a large family of β-trefoil polypeptide growth
factors involved in various important biological processes such as development and
maintenance of cells. Proteoglycans, such as heparin, are required for the cell proliferation
activities of FGFs. The three-dimensional structure of the FGF-heparin complex shows that
the sulfate groups in the proteoglycans contribute significantly to binding. In the present
study, we used a site-directed mutagenesis approach to design FGF with increased heparin
binding affinity. Several residues in the heparin-binding loop of human acidic fibroblast
growth factor (hFGF-1) were replaced with lysine residues. The effects of the mutations on
heparin binding affinity and thermodynamic stability were assessed.

Introduction
Fibroblast growth factors (FGFs) play significant roles in the regulation of cell
proliferation, angiogenesis, differentiation, tumor formation, embryonic growth, invasion,
inflammation, and tissue repair.1,2 FGFs are also able to improve wound healing caused by
metabolic diseases such as obesity, diabetes, infection, chronic liver failure, malnutrition, and
second-degree burns. To date, at least 23 FGFs have been discovered, named consecutively
FGF-1 to FGF-23. FGFs are about 154 amino acids long and are believed to share a common
core of 140 amino acids, of which 28 residues are highly conserved and 6 residues are invariant.3
FGFs are all beta-barrel proteins and contain no disulfide bonds. Studies have indicated that
FGFs produce biological responses by binding to two types of receptors on the cell surface.2,4-5
The first class is a high-affinity family of transmembrane tyrosine kinase receptors called
FGFRs. The second class of receptors is the family of heparan sulfate proteoglycans (HSPGs),
which have a low affinity for FGFs.6 The macromolecular interactions of the growth factors,
HSPGs, and FGFR that lead to signal transduction are key to signaling by this important class of
molecules.7
The binding of FGFs to FGFRs plays an essential role in the biological activation of
FGFs.8 Four FGFRs have been identified in humans and are well conserved throughout
evolution.9 Alternate splicing results in binding specificity for the various members of the FGF
family.10 Of the known FGFs, only FGF-1 and FGF-2 are universal ligands and can bind to all
FGFRs.8 The prototype FGFR structure consists of an extracellular region, a transmembrane
helix domain, and an intracellular tyrosine kinase domain. The common extracellular ligandbinding domain is comprised of three immunoglobulin-like (Ig-like) domains - D1, D2, and D3 each of which contains a disulfide bridge.12 Studies have shown that the interaction of FGFs with
domains D2-D3 is a minimum requirement for sufficient ligand binding.13 Binding of FGF to
FGFR leads to receptor dimerization and subsequent tyrosine autophosphorylation and
phosphorylation of target molecules, which initiates a phosphorylation cascade within the cell
that culminates in multiple cellular outcomes.14
9

Crucial for the dimerization of the tyrosine kinases are heparan sulfate proteoglycans.15,16
HSPGs are polymers of disaccharide repeats, which are mostly highly sulfated and negatively
charged.18 HSPGs are found in the extracellular matrix adjacent to cell surfaces and as integral
components of the plasma membrane.19 Several different mechanisms have been proposed for
the role of heparin in the mitogenic activity of FGFs and formation of the FGF-FGFR complex.
The absence of HSPGs on the cell surfaces reduces FGF oligomerization, which affects FGF
binding to FGFR(s) and lowers FGFR activity for cell proliferation.20 The interaction of heparin
with FGFs stabilizes the protein against thermal denaturation, proteolysis, FGF release into
interstitial spaces and limits diffusion.21 Binding also increases mitogenesis, wound healing, and
neuro-vascularization.22 Additionally, heparin helps to increase the affinity and half-life of the
FGF-FGFR complex, which is crucial for signal transduction.23 Residues involved in heparin
binding correspond to amino acid 126 to 142 of the human FGF-1 sequence. In this context, we
examined the role of additional lysine residues in the putative heparin-binding region of wildtype FGF-1, as introduced by single and double -site mutagenesis on binding, stability, and
structure using various biophysical techniques including multi-dimensional NMR spectroscopy.
The results clearly indicate that the introduction of lysine residues in positions N128, Y139, and
Q141 in the heparin-binding pocket significantly increases binding to sucrose octasulfate (SOS, a
heparin analog) and conformational stability. In addition, results of this study provide a valuable
basis for novel therapeutics targeting this interaction.

Experimental Procedure
Materials: Taq DNA polymerase, NdeI, and XhoI enzymes were purchased from Promega.
Escherichia coli [BL21(DE3)pLysS] and pET20b(+) were purchased from Novagen. Sucrose
octasulfate (SOS) and heparin-Sepharose were obtained from Toronto Research Chemicals
(Toronto, ON) and Amersham Biosciences, respectively. Labeled 15NH 4 Cl, and D 2 O were
purchased from Cambridge Isotope Laboratories. Urea, guanidine hydrochloride,
phenylmethylsulfonyl fluoride, TritonX-100, and beta-mercaptoethanol were obtained from
Sigma Chemical Co. All other chemicals used in this study were of high-quality analytical grade.
FGF-1 Expression: The FGF-1 gene was inserted between EcoRI and NdeI restriction sites of
the pET18b plasmid of pLysS E coli. Cultures were grown in LB medium (25g/L) in presence
of ampilicin and chloramphenicol at 37°C. Overnight pre-culture was grown from glycerol
stock. Large-scale cultures were induced with 1mM of IPTG once the optical density at 600 nm
reached 0.6, then the cultures were allowed to grow for another 5 hours at 37°C and 165 rpm.
The cultures were centrifuged and the pellet was resuspended in a 10 mM phosphate buffer
containing ethylenediaminetetraacetic acid (EDTA), Triton, beta-mercaptoethanol, and
phenylmethylsulphonyl fluoride (PMSF) at pH 7.2.
Protein Purification: The proteins were extracted from the resuspended bacteria by sonification
and centrifugation; the proteins were over-expressed in the supernatant, which was loaded onto a
heparin-Sepharose column. The column was washed sequentially with 10 mM phosphate buffer
containing 0 M NaCl, 0.8 M NaCl, 1.5 M NaCl, and 2.0 M NaCl. The proteins eluted in the 1.5-2
M NaCl fractions. SDS-PAGE was used to visualize the purity of the protein fractions. The
protein was desalted using 10 mM phosphate + 100 mM NaCl + 50 mM ammonium sulfate
buffer (pH 7.2).
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Mutagenesis: Single amino acid mutations were introduced using a QuikChange site-directed
mutagenesis kit. The primers used were, for N128K: forward: 5’ - TTT GTT GGC CTC AAG
AAG AAG GGG AGC TGC AAA CGC GGT – 3’; reverse: 5’ – ACC GCG TTT GCA GCT
CCC CTT CTT CTT GAG GCC AAC AAA – 3’. For T137K: forward: 5’ – CGC GGT CCT
CGG AAA CAC TAT GGC CAG AAA GC – 3’; reverse: 5’ – GC TTT CTG GCC ATA
GTG TTT CCG AGG ACC GCG – 3’. For Y139K: forward: 5’ – CGC GGT CCT CGG ACT
CAC AAA GGC CAG AAA GCA ATC TTG - 3’; reverse: 5’ –CAA GAT TGC TTT CAG
GCC TTT GTG AGT CCG AGG ACC GCG – 3’. For Q141K: forward: 5’ - GGT CCT CGG
ACT CAC TAT GGC AAG AAA GCA ATC TTG TTT CTC CCC – 3’; reverse: 5’ – GGG
GAG AAA CAA GAT TGC TTT CTT GCC ATA GTG AGT CCG AGG ACC – 3’. The
underlined bases represent the base changes from the WT sequence.
The double mutation was introduced by creating an insert using PCR, using the N128K
plasmid as a template, T7 promoter forward primer, and a reverse primer that introduced a
mutation at the 139 position, or mutations at the 139 and the 141 positions. The insert was
ligated into the pET20b plasmid vector using the NdeI and EcoRI restriction sites. The primer
for the N128K/139K mutation was 5'- CGA ATT CGG ATC TCT TTC ATC AGA AGA GAC
TGG CAG GGG GAG AAA CAA GAT TGC TTT CTG GCC TTT GTG AGT CCG AGG ACC
GCG -3'. The primer for the N128K/139K/Q141K mutation was 5'- CGA ATT CGG ATC TCT
TTC ATC AGA AGA GAC TGG CAG GGG GAG AAA CAA GAT TGC TTT CTT GCC TTT
GTG AGT CCG AGG ACC GCG -3'. The underlined bases represent the base changes from the
WT sequence.
Steady-State Fluorescence: Urea denaturation, guanidine hydrochloride denaturation, and
thermal denaturation were measured using a Hitachi F-2500 Fluorescence spectrophotometer.
Fluorescence was measured at 308 nm and 350 nm. Thermal denaturation was conducted from
9-84°C at 2-3°C intervals. Temperature was maintained using a circulating water bath. Urea
denaturation was conducted over the range 0.0 – 6.0 M urea at 0.2 M increments. Guanidine
hydrochloride denaturation was conducted over the range from 0.0 to 5.0 M, at 0.2 M
increments. 6.0 M urea or 5.0 M GdnHCl was used to achieve the correct molarity; samples
were brought to volume using a 10 mM phosphate, 100 mM NaCl, 50 mM ammonium sulfate
buffer (pH 7.2). Concentration of protein used was 20 µM. The urea, GdnHCl, and thermal
denaturation experiments were performed in presence and absence of SOS.
Proteolytic Digestion Assay: The limited proteolytic experiments on FGF-1 and the FGF-1-SOS
mixture (1:1) were carried out (at 37 ± 2 C) using trypsin. Proteolytic digestions were
performed at an enzyme (trypsin)/substrate (FGF-1) molar ratio of 1:10. The protease activity
was stopped after a desired time interval by the addition tricholoroacetic acid and placement on
ice. The degree of proteolytic cleavage was measured from the intensity of the ~16-kDa band on
a SDS-PAGE gel using a densitometer. The intensity of the ~16-kDa band corresponding to
FGF-1 not subjected to protease treatment was considered the control for 100% protection
against trypsin cleavage.
Differential Scanning Calorimetry: Thermal-induced unfolding was performed in a Nano III
DSC (Calorimetry Sciences Corp.) fitted with a capillary cell. All of the samples were degassed
for 2 min at room temperature prior to loading. The scan rates was 1°C/min. Thermograms of
11

proteins (0.5 mg/mL) alone and in the presence of SOS/heparin were obtained from 10 to 80 °C
using a scan rate of 1°C/min. The filled cells were equilibrated for 10 min at 10°C before the
beginning of each scan. Before each experiment, buffer blank experiments were run to obtain a
stable baseline. Thermograms of the buffer alone were subtracted from each protein scan prior to
analysis using software supplied by Calorimetry Sciences Corp.
Isothermal Calorimetry: Binding of SOS/heparin to FGF-1 was analyzed by measuring the heat
change during the titration the protein solution with of SOS/heparin using a VP-ITC titration
microcalorimeter (MicroCal, Inc., Northampton, MA). All protein and ligand (SOS/heparin)
solutions were degassed under vacuum and equilibrated at 25 C prior to titration. The sample
cell (1.4 mL) contained 0.04 mM FGF-1 dissolved in 10 mM phosphate buffer (pH 7.2)
containing 100 mM NaCl and 50 mM ammonium sulfate. The reference cell contained water.
Upon equilibration, 0.5 to 0.6 mM SOS/heparin was injected in 47 × 6 µL aliquots using the
default injection rate of 300 s intervals between each injection to allow the sample to return to
the baseline. The resulting titration curves were corrected with the protein-free buffer control and
analyzed using the software supplied by Microcal, Inc.
NMR Experiments: All NMR experiments were performed on a Bruker Avance-700 MHz NMR
spectrometer equipped with a cryoprobe at 25 C. 15N decoupling during acquisition was
accomplished using the globally optimized altering-phase rectangular pulse sequence. Spectra
were acquired with 8 transients of 1024 data points and 64 t 1 increments. The HSQC spectra
were recorded at 32 scans at all concentrations of SOS. The concentration of the protein sample
was 0.5 mM in 95% H 2 O and 5% D 2 O [10 mM phos (pH 7.2)] containing 100 mM NaCl and 50
mM AMS. All of the spectra were processed on a Windows workstation using XWIN-NMR and
Sparky softwares.24

Results and Discussion
Human FGF-1 has 12 beta-strands arranged into a beta-trefoil motif. A dense cluster of
positively charged residues located in the loop between beta-strands 10 and 11 constitutes the
heparin-binding site (Figure 1). In this study, neutral and negatively charged amino acids in the
in the putative sugar-binding region were changed to the basic amino acid lysine. Specifically,
mutations were created in positions N128, Y139, and Q141 (Figure 1). Binding affinity
experiments were carried out with heparin and sucrose octasulfate (SOS). SOS is a polysulfated
heparin analog commonly used as a structural and functional mimic for heparin. The chemical
structure of SOS with its eight sulfate residues resembles the repeating disaccharide units of
heparin. SOS has also been widely used as an antiulcer drug and has been shown to accelerate
ulcer healing without reducing gastric acids.28
SOS binding to hFGF-1. Isothermal titration calorimetry (ITC) is a versatile technique used to
characterize protein-protein or protein-ligand interactions.25 ITC experiments provide direct
information about the stoichiometry, affinity, and enthalpy of protein-ligand binding reactions.24
The binding isotherm characterizing SOS/heparin-hFGF-1 interaction is nearly sigmoidal (Figure
2). The interaction proceeds with the evolution of heat with negative enthalpy, suggesting that
electrostatic interactions play a predominant role in the protein/SOS interactions. The binding
isotherm best fits a one-site binding model yielding binding constant values of 2.237 x10-5 M for
12

SOS and 5.128 x10-6 M for heparin. These results of show that hFGF-1 interacts with
SOS/heparin and that one molecule of the protein appears to bind one molecule of SOS/heparin.
The binding affinity shared by SOS and hFGF-1 was re-examined in three different single-point
mutants (N128K, Y139K, and Q141K) and in a double point mutant (N128K/Y139K) (Figure 2).
All three single point mutants showed 10-fold increase in their binding affinity to SOS (~10-6
M); moreover, the double mutant showed significant increase (~100-fold) both in SOS and
heparin binding affinity (~10-7 M) compared to the wild type hFGF-1 (Figure 2). Table 1
provides a summary of the thermodynamic data for the all of the ITC experiments. The ITC data
clearly suggests that the lysine mutants of hFGF-1 are indeed in biologically active conformation
and binds to SOS more strongly than the wild type.
hFGF-1 mutants are stabilized by SOS/heparin binding. Differential Scanning Calorimetry
(DSC) is a thermo-analytical technique in which the difference in the amount of heat required to
increase the temperature of a sample and reference are measured as a function of temperature.26
Both the sample and reference are kept at the same temperature throughout the experiment. In
this context, we performed thermal denaturation of hFGF-1-wild type, three single-point mutants
(N128K, Y139K, and Q141K) and the double mutant (N128K/Y139K) in absence and in
presence of SOS/heparin (Figure. 3). The data shown in Figure 3 was corrected for a linear
native baseline. There is an increase in the midpoint transition temperature from ~51.5°C for
hFGF-1-WT alone to T m ~63.5°C in the presence of SOS and 67.1 °C in the presence of heparin.
The T m difference between the WT without and with ligand was ~ 12. 5°C for SOS and ~15.6°C
for heparin. All the single point mutants (N128K, Y139K, and Q141K) showed a slight increase
in the difference in transition temperature- around ~12.9°C in the presence of SOS. However, the
double mutant (N128K/Y139K) showed significant increase in the transition temperature, both in
the presence of SOS and heparin (~14.2°C and 18.2°C, respectively) as compared to the wild
type. The thermal transition of wild type, single, and double mutants of hFGF-1 are irreversible.
Table 2 gives a summary of the transition temperatures.
Stability monitored by fluorescence thermal denaturation. The emission spectrum of native
hFGF-1 is dominated by a tyrosine emission peak at 308 nm. In the completely unfolded state (in
8 M urea), FGF-1 exhibits an emission spectrum that is dominated by a single well-conserved
tryptophan at position 121,27 which fluoresces at 350 nm. These spectral features are ideal for
monitoring the denaturant-induced unfolding of the protein and also serve as an excellent probe
for monitoring the tertiary structural changes that occur in the protein under different conditions.
Equilibrium thermal denaturation of wild type and the N128K/Y139K double mutant of hFGF-1
were performed to assess the conformational stability of the protein upon binding with SOS
(Figure 4A). The T m (the temperature at which 50% of the molecules are in the native state) of
the double mutant (N128K/Y139K) increased in the presence of the SOS by about 5.4°C (from
44.7°C to 50.1°C). In contrast, the T m of the double mutant increased in by about 11.2° C (from
42.6 °C to 53.8°C), suggesting that thermodynamic stability of the double mutant is enhanced
upon binding to the SOS as compared to the wild type.
Stability monitored by Gdn-HCl/urea induced denaturation. Unfolding of wild type hFGF-1
monitored by steady state fluorescence reveals that the wild type hFGF-1 is completely unfolded
beyond 1.6 M guanidine hydrochloride (Figure 4B). The C m (concentration of the denaturant at
which 50% of the protein is unfolded) values of the unfolding curves for wild type hFGF-1
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obtained in absence and in presence of SOS are 1.25 M and 1.75 M, respectively. Unfolding of
N128K/Y139K double mutant is completely unfolded beyond 1.4 M GdnHCl (Figure 3B), but in
contrast to wild type, the C m values of the double mutant obtained in absence and in presence of
SOS are 1.05 M and 1.85, respectively. Additionally, urea-induced unfolding of wild type and
double mutant was investigated to determine whether the stability is dependent on the nature of
the denaturant. The C m values of the unfolding curves for wild type hFGF-1 obtained in absence
and in presence of SOS are 2.38 M and 3.40 M, respectively (Figure 4C), but in contrast to the
wild type the C m values of the double mutant obtained in absence and in presence of SOS are
2.40 M and 3.75 M, respectively. All the above stability experiments suggest that
thermodynamic stability of the double mutant is enhanced upon binding to SOS.
Proteolytic digestion. Limited proteolytic digestion is a popular technique used to probe the
protein-ligand interactions.29 Proteolytic digestion, in general, is governed not only by
stereochemistry and accessibility of the protein substrate but also by the specificity of the
proteolytic enzyme. In principle, binding of a ligand/drug can potentially mask the cleavage
sites in the protein substrate, and these subtle differences in the cleavage patterns (between the
free and the ligand/drug-bound protein substrate) could be easily detected by SDS-PAGE
analysis. Because hFGF-1 is rich in arginine and lysine residues, we performed limited trypsin
digestion to probe the binding of SOS to wild type and N128K/Y139K double mutant of hFGF1. Time-dependent trypsin digestion of the proteins in the free and SOS-bound forms was
monitored by SDS-PAGE analysis using Coomassie Blue staining. The degree of digestion was
measured based on the intensity of the undigested hFGF-1 ~16-kDa band. The tryptic digests of
wild type hFGF-1, obtained in the presence and absence of SOS, clearly revealed that the protein
bound to SOS has increased resistance to proteolytic cleavage (Figure 5A). The enhanced
resistance to trypsin cleavage could be due to masking of some of the potential enzyme cleavage
sites in hFGF-1 by SOS. The N128K/Y139K double mutant trypsin digestion showed more
resistance than the wild type in the presence of SOS. Densitometric scans of the undigested
hFGF-1 band obtained after various time periods of incubation of the protein with trypsin, show
that the double mutant is stabilized more than the wild type in the presence of SOS. More than
92% of the ~16 kDa double mutant of hFGF-1 band remains intact in the presence of SOS after
180 min (Figure 5B). These results clearly indicate that SOS binds to the double mutant of
hFGF-1 with high-affinity and sterically restricts the exposure of the trypsin cleavage sites in the
SOS-binding site.
Identification of SOS binding site(s) on hFGF-1. NMR spectroscopy is a versatile technique to
map the protein-drug interface with atomic resolution and also to measure the binding affinity
and stoichiometry of protein-ligand interactions.25 The 1H-15N HSQC spectrum is a fingerprint of
the conformational state(s) of the protein. Each cross-peak in the spectrum represents an amino
acid in a particular conformational state of the protein. Therefore, the conformational changes
and ligand-binding site(s) in a protein can be conveniently identified by the chemical-shift
perturbation/disappearance of cross-peaks in the 1H-15N HSQC spectrum. The overlapped
spectra of the wild type and N128K/Y139K double mutant shows that most of the cross-peaks
from wild type are retained, except for the residues that are mutated and those adjacent to the
mutated residues (Figure 6A). The data shows that the backbone conformation of the double
mutant is very similar to that of wild type. 1H-15N HSQC spectra of wild type hFGF-1 acquired
at various hFGF-1/SOS ratios revealed that only a few cross-peaks were perturbed from their
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original positions in the native-state spectrum (Figure 6B). The residues that exhibit
prominent 1H-15N chemical-shift perturbations are located in stand XI and the loops between
strands X and XI and strands XI and XII (Figure 6C).

Conclusion
The results obtained in this study clearly show that the incorporation of additional lysine residues
significantly increases the heparin/SOS binding affinity. In addition, the thermodynamic stability
of the mutant forms of hFGF-1 is also significantly enhanced upon binding to SOS. We also
demonstrated that the conformation of the hFGF-1 is not significantly perturbed. Work is in
progress to investigate the mitogenic activity of the various designed mutants of hFGF-1.
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Figure Legends
Figure 1. MolMol representation of hFGF-1. The heparin-binding region is mostly located in
beta strand XI, the loop between strands X and XI and the loop between strands XI and XII,
which is in the tip right section of the figure. The three amino acids mutated in this study are
shown.
Figure 2. ITC curves showing the binding of SOS/heparin to wild type and mutants of hFGF-1
at 25 °C. The upper panels show the raw data representing hFGF-1 – SOS titration. The bottom
panels show the integrated data obtained from the raw data after background subtraction. The
solid line in the bottom panels represents the best-fit curve of the experimental data, using the
one site and sequential binding site(s) model from Microcal Origin.
Figure 3. Differential scanning calorimetry thermograms representing the unfolding of wild type
and mutants of hFGF-1. The protein (0.5 mg/mL) was dissolved in 10 mM phosphate buffer (pH
7.2) containing 100 mM NaCl and 50 mM ammonium sulfate. Thermograms were corrected for
background noise. The experiments were performed at a scan rate of 1°C/min.
Figure 4. Panels A, B, and C represent the equilibrium unfolding of the wild type hFGF-1 and
the N128K/Y139K double mutant of hFGF-1 in absence and presence of SOS, induced by
thermal, guanidine hydrochloride, and urea, respectively. The denaturation were monitored by
steady-state fluorescence at 350 nm. The binding of SOS provides additional stability to the
double mutant as compared to the wild type hFGF-1.
Figure 5. Time-dependent trypsin digestion of the wild type and N128K/Y139K double mutant
of hFGF-1 in absence and presence of SOS. Lanes 1 through 9 represent the trypsin digestion
products formed after 0 min (lane 1), 15 min (lane 2), 30 min (lane 3), 45 min (lane 4), 60 min
(lane 5), 90 min (lane 6), 120 min (lane 7), 150 min (lane 8) and 180 min (lane 9). Panel B
represents the densitometry scan of the band corresponding to hFGF-1 wild type and the
N128K/Y139K mutant band (~16 kDa). The concentration of the protein and SOS used were
0.05 mM and 0.5 mM, respectively.
Figure 6. Panel A- 1H-15N HSQC spectra of wild type hFGF-1 obtained in the absence (darker)
and presence (lighter) of SOS. The significant chemical shift perturbation observed in the
presence of SOS indicates that these residues are in the vicinity of the SOS site(s). Panel BOverlap of the 1H-15N HSQC spectra of N128K/Y139K double mutant (lighter) and wild type
hFGF-1 (darker). Panel C- 1H-15N chemical shift perturbation of residues in hFGF-1 in the
presence of SOS. The amino acid residues in hFGF-1 that exhibited significant chemical shift
perturbation and are involved in SOS binding are indicated by the residue number. Panel DMolMol representation of the structure of hFGF-1. Residues which exhibit prominent chemicalshift perturbation are in the lighter section. The residues constituting the SOS binding site(s) are
mostly located in beta strand XI and the loops between strands X and XI and strands XI and XII.
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Table 1

Table1. Depicting the binding constant (Kd) characterizing SOS-hFGF-1.
Sample

Kd

FGF-1-WT Vs SOS

2.237x10-5

FGF-1-WT Vs Heparin

5.128x10-6

N128K Vs SOS

Kd1-6.535x10-5
Kd2-4.761x10-5
Kd3-2.475x10-4

Y139K Vs SOS

6.896x10-6
Kd1- 3.597x10-6
Kd2- 2.237x10-5
Kd3- 3.105x10-5

Q141 Vs SOS

N128K/Y139K Vs SOS

9.708x10-7

N128K/Y139K Vs Heparin

2.785x10-7

Table 2
Table 2. Depicting the Tm Values from DSC
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Investigations of an Immunoassay-Compatible Species for
Pumping with Magnetohydrodynamic Force
Christena Hooten, University of Arkansas
Fayetteville, Arkansas

Abstract
To use Magnetohydrodynamic flow to automate the building of a sandwich immunoassay
containing alkaline phosphatase (AP), a compatible redox pumping species must be found.
To be a suitable pumping species for this method, the species must undergo
electrochemistry without perturbing the enzyme generated product, p-aminophenol (PAP).
Through cyclic voltammetry, my research demonstrates the electrochemical compatibility
of ruthenium (III) hexamine with PAP. My research also shows solution flow using PAP
itself as the pumping species at concentrations as low as 4 mM.

Introduction
The demand for handheld devices in healthcare, food sciences, and environmental
sciences has been the subject of recent research. Electrochemical detection has been identified
as a good way to produce small, affordable biosensors. An immunoassay, which can be
combined with electrochemical detection, uses the specific binding between an antigen and its
antibody to measure the analyte (the antigen) concentration in complex matrixes5 (figure 1) and
only requires nanoliter volutes of solution.1 Immunoassays have been built on multiple
substrates including glass, silicon, and gold, giving it a wide variety of applications.3 One of the
goals of the lab-on-a-chip (LOAC) devices is to develop an automated method that combines
injection and pumping of wash solutions and immunoassay components, with analytical
detection processes4. A different kind of LOAC application is to carry out compound synthesis
and reagent-product separation. The automation of such multi-step LOAC can only be carried
out through the use of microfluidics. There are several ways to perform microfluidic pumping
and all of thos methods have different advantages and disadvantages. The method investigated
here, redox-magnetohydrodynamics (redox-MHD), is quite new, but may be very useful because
it exhibits characteristics that complement the existing set of pumps. To date there are only a
few publications on redox-MHD,6,7 but the concentrations of redox species used to show an
MHD effect are so high at the low magnetic fields used in portable devices that it puts into
question the usability of this method for biochemical applications. This paper resolves this
question.
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Figure 1 is a schematic of a sandwich immunoassay.

MHD occurs when a net flux of ions (j) interacts with the perpendicular component of the
magnetic flux density (B), creating a Lorentz force, F MHD in a third direction governed by the
right hand rule, j x B = F MHD . This force is sufficient to produce microfluidic pumping and the
direction of flow can be reversed by reversing the polarity of an electrode (e.g. changing the
potential from oxidizing to reducing values or visa versa) at which the ions are generated or used
up. The MHD pumping method described in this paper uses two working electrodes. These
electrodes are held at potentials of equal magnitude, but opposite sign. This creates circular flow
around the working electrodes in opposite direction (figure 2). Although the flows are opposite
in direction, the flow combines coming down the middle of the array, and can increase the flow
rate.

Figure 2 illustrates reinforcing flow MHD.

Magnetohydrodynamic flow is a way to manage solution flow without requiring highly
skilled laboratory technique. Antigen-antibody binding is limited by mass transport, not binding
kinetics;2 therefore, the convection flow created by MHD will also decrease incubation times.
To date, no research has been performed to find a redox pumping species that is compatible with
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biochemical substances such as antibodies, enzymes (e.g. alkaline phosphatase, AP), enzyme
substrates (e.g. p-aminophenylphosphate, PAPP), and enzyme-generated products (e.g. paminophenol, PAP). The most suitable choice for a redox pumping species should undergo
electrochemistry at a different potential than that for enzyme substrate and should not react with
any component of the immunoassay. It is also highly desirable that the redox pumping species
does not alter the composition of the enzyme generated product. This paper reports two suitable
redox species for MHD pumping and shows that fluid flow can be seen at low redox
concentrations.

Experimental Procedures
Chemicals. All chemicals were reagent grade and used as received. Aqueous solutions were
prepared using high-purity deionized (DI) water from Ricca. The 0.1 M Tris buffer was
prepared with 0.1M tris (hydoxymethyl)aminomethane from J. T. Baker, 1 mM magnesium
chloride from Fisher Chemical, and 0.02% (w/v) sodium azide from Sigma and was adjusted to
pH 9.0 with 6 M HCl. Ruthenium (II) hexamine chloride, potassium ferrocyanide, and paminophenol were obtained from Aldrich.
Electrochemical Measurements. A CH Instruments potentiostat was used to perform cyclic
voltammetry (CV) on solutions containing redox species. A three electrode setup containing a
10 μm Au polished disk electrode from CH Instruments as the working electrode, a Pt flag
electrode as the auxiliary electrode, and Ag/AgCl (saturated KCl) electrode as the reference
electrode.
MHD Methods. A microband array was used to perform electrochemistry on a 4 mM solution
of PAP. A MHD reinforcing flow electrode configuration was used to create solution flow. Two
sets of three 50 μm bands were shorted together to make two working electrodes on opposite
sides of the microband array. One working electrode was held at a potential of +0.3 V. The
working electrode on the opposite side was held at a potential of -0.3 V. A larger gold counter
electrode and polarizable gold pseudoreference electrode, also fabricated on-chip, were used to
complete the circuit. Water containing 10 μm diameter polystyrene beads from Alpha Aesar was
pipetted into the solution diluting the bead solution by 200 times. With the aid of a microscope,
the bead movement was observed and filmed. Particle tracking software was used to measure
the bead speed. The procedure and setup is much like that used in our laboratory previously by
Anderson et al.8

Results and Discussion
Finding a Suitable Redox Pumping Species. A typical immunoassay involving
electrochemical detection uses an alkaline phosphatase (AP) label conjugated to the secondary
antibody to convert p-aminophenylphosphate (PAPP) to p-aminophenol (PAP). It is the PAP
which is elctroactive and undergoes a 2-electron oxidation to form a quinoneimine at the
electrode, leading to the electrochemical signal. The usual concentration of the PAPP enzyme
substrate is 4 mM in a pH 9 Tris buffer in these kinds of heterogeneous sandwich assays. The
basic buffer allows the AP to be most active.
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It is important that the redox pumping species not convert the PAPP directly to PAP,
which would preclude the use of the electrochemical signal from PAP to quantify the assay. In
all of the studies with the species described below, we first confirmed that PAPP was
undisturbed in the presence of the pumping redox species.
Second, we determined whether the electrochemical behavior of the pumping species and
PAP would be sufficiently compatible so that we could still be able to quantify the amount of
PAP in the solution. Details of these latter experiments are shown below. The maximum signal
that an assay would be able to provide for a 4 mM PAPP solution would be one be one where
complete enzymatic conversion to PAP (4 mM) occurs. Thus, in the experiments described in
this section, a 4 mM concentration of PAP was used.
The first redox pumping species that was investigated was 6 mM potassium ferrocyanide
in 0.1 M Tris. We originally selected ferrocyanide, because in previous studies in our laboratory,
the E˚ value was more negative of that of PAP in our supporting KCl electrolyte. However, in
the basic pH Tris buffer, the E° value of ferrocyanide shifted to a value that was at such a
positive potential that its oxidation was indistinguishable from the oxidation of PAP (figure 3).
Therefore, ferrocyanide is not a suitable pumping species because at the potential needed to
oxidize ferrocyanide to ferricyanide to create MHD pumping will also oxidize the PAP. In
addition, if both ferrocyanide and ferricyanide were present in solution so that oxidation and
reduction of the redox species could both take place at tow electrodes (as in the reinforcing flow
configuration in figure 2), homogeneous oxidation of PAP would also take place in a reaction
with the ferricyanide in the bulk solution.
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Figure 3 shows that PAP and ferrocyanide are electrochemically indistinguishable.

Another redox species that was investigated for microfluidic pumping with MHD was 6
mM ruthenium (II) hexamine (ruhex). The ruhex is able to oxidize at a negative enough
potential that PAP is left undisturbed (figure 4). This makes ruhex a suitable MHD pumping
species. A mixture of the oxidized and reduced forms of ruhex could be used in a reinforced
MHD flow method to increase solution flow rate.
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Figure 4 shows that the oxidation of ruhex is distinguishable from the oxidation of PAP, making ruhex a suitable
pumping species.

The studies involving ferrocyanide led us to try MHD directly with a solution of 4 mM
PAP alone in Tris. The argument supporting this simplified composition is that if the oxidation
state of the PAP is going to be changed as a consequence of pumping, then it is not necessary to
ad any additional species. Also, we would know exactly the amount of PAP we added to start
with and could then determine any additional species generated by the reaction of AP with PAPP
by difference in the signal (figure 5). Of course, the compatibility of PAP and immunoassay
components is already well known. The current from the enzyme-generated PAP would be
proportional to the amount of analyte (or antigen) captured by the assay.
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Figure 5 shows a CV of 4 mM PAP and the expected CV of 4 mM PAP and 4 mM PAPP in the presence of AP.

MHD Effects Seen in 4 mM PAP. The reinforcing MHD flow method was used to observe
bead movement in 4 mM PAP. In these experiments, the speed of the beads is assumed to be a
good estimate of solution flow velocity. Because only PAP oxidizes, flow in a circular path
around the anode was observed. However, because there was no other species that could reduce
at the potential held at the cathode, the current there was negligible, and therefore, no flow was
observed there.
A chronoamerogram (CA) was taken at the anode and the absolute current over time was
plotted (figure 6).
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Figure 6 shows an initially high current followed by a steady state current.

The CA of 4 mM PAP showed a high initial current. Due to this high Faradaic transient
when the CA is started, the higher ion flux results in a larger F MHD . This manifests itself as a
higher bead velocity at early times. As time passes, the current decreases, reaching a steady
state. The bead velocity is correspondingly slow to a steady-state, as well as, expected from the
cross product relationship of j and B.
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Figure 7 shows the initially high bead speed, which becomes steady over time.

The higher the current, the larger the ion flux, the greater the MHD force and the faster
the beads move (figures 6 and 7). The fastest speed that beads traveled was 17.1 μm/s. This is a
sufficient flow rate for building an immunoassay and is competitive with other MHD fluid
velocities (that range from 1 μm/s to 1 mm/s) reported in the literature for solutions that do not
contain redox species. The added advantage of the redox species is that electrode corrosion and
electrolysis of solutions (that produces bubbles) are avoided.

Conclusion
This research found two suitable redox-MHD pumping species that can be used at very
low concentrations (4-6 mM) and would be expected to be compatible with immunoassay
components (ruthenium (III) hexamine and PAP in Tris buffer). Ruhex is a good pumping
species because both its oxidized and reduced forms are compatible with PAP, making it a good
species for reinforced MHD flow. PAP alone can serve as a pumping species and it is known to
be compatible with immunoassay components. The added current from the enzyme generated
PAP over the starting PAP signal would be proportional to the analyte in an assay. Changes in
signal of 1/10 should be easily quantifiable, and sufficient for analysis by immunoassay. This
paper also reports solution flow up to 17.1 μm/s in a 4 mM solution of PAP (in Tris). This value
is competitive with velocities reported in the literature for non-redox MHD, which range from 1
μm/s to 1 mm/s. If we make use of the reinforcing flow configuration with the use of both
oxidized and reducd forms of ruhex, we expect that velocities of at least 2.5 times will be
achievable8. Future work will involve reinforcing flow investigations and other electrode
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geometries to optimize velocities while keeping the pumping species concentration low. A
complete immunoassay will also be performed in the presence of the compatible redox pumping
species under optimized conditions to demonstrate the utility of redox-MHD for LOAC
applications.
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The Enhancement of In Vitro Microdialysis Recovery of
Interferon-γ Using Affinity Agents
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Abstract
Microdialysis is a common way to sample small, low molecular weight analytes. In living
tissue it has become increasingly important to study small signaling proteins called
cytokines, which are vital for cellular communication. One cytokine of interest is
Interferon-γ (IFN-γ). This cytokine plays a major role in immune response to foreign
agents and it is of interest to know concentrations of IFN-γ in living tissue. One issue that
arises with cytokine microdialysis is a general low relative recovery. Some affinity agents,
such as heparin, can bind cytokines and increase relative recovery. This project aims to
study the relative recovery of Interferon-γ using microdialysis. To this end, two known
affinity agents, heparin and the detection antibody for IFN-γ, were used to increase the flux
of cytokine into the microdialysis probe. Dialysate samples were collected and analyzed by
ELISA.

Introduction
In living tissue it has become increasingly important to study small signaling proteins
called cytokines. These proteins are vital for cellular communication. In the fields of
pharmacokinetics and neuroscience, it is especially important to have a quantitative measurement
of cytokine concentrations. Until recent years it has been very difficult to get real time
information on cytokine concentrations in living tissue. Microdialysis sampling is widely used
to sample cytokines. In vivo, a small microdialysis probe is inserted into the tissue. A buffer
solution is perfused through the probe and cytokines diffuse through the membrane. A sample
can be collected in few hours and can give close to real time data of cytokine concentrations.
Also, microdialysis is reasonably inexpensive and is less evasive then previous sampling
techniques.
One issue that arises with collecting cytokines via microdialysis is a general low relative
recovery (RR).

RR =

Ccollected
C sample

(1)

This is due to several factors including, size and conformation of the cytokine, interactions
between the cytokine and the probe, and flow rate of perfusion fluid. The use of affinity agents
is now commonly used to increase cytokine recovery. Affinity agents can bind to the cytokine
and change the concentration gradient, effectively enhancing the flow of the cytokine into the
probe. Heparin, a naturally occurring glycosaminoglycan, is negatively charged and can bind
several common cytokines.1, 2 Recent studies have shown an increase in relative recovery with
perfusion fluid containing heparin.3, 4 Cytokine antibodies have also been used to increase
relative recovery.
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One specific cytokine of interest is Interferon-γ. It is the only member of the type II class
of interferons. Interferons are naturally occurring proteins produced by cells of the immune
system in response to foreign agents, such as viruses. Specifically, IFN-γ activates natural killer
cells and macrophages, up-regulates antigen presence in lymphocytes, and induces resistance of
host cells to viral infection.5 A bioengineered form of IFN-γ has been used in children and adults
with chronic granulomatous disease and severe, malignant osteopetrosis. Because IFN-γ can
also cause inflammation, it may be of interest to know specific concentrations of the cytokine
during infection. This study aims to use affinity agents to increase the relative recovery in vitro
microdialysis sampling of IFN-γ.

Experimental Procedures
Materials
Heparin Sodium Salt (Grade 1-A from Porcine Intestinal Mucosa) was purchased from SigmaAldrich (St. Louis, MO). Rat IFN-γ ELISA kit was purchased from BD Biosciences Pharmigen
(San Diego, CA). Rat IFN-γ standards from the ELISA kit were used in all experiments. The
buffer for all experiments was the ELISA kit buffer (PBS with 10% FBS, pH 7.0).
Microdialysis
For all microdialysis experiments the CMA/20 (10mm) Polyethersulfone (PES) probes with
100kDa cut off (CMA/Microdialysis AB, Stockholm, Sweden) were used. The probes were
connected to CMA402 syringe pumps (CMA/Microdialysis AB, Stockholm, Sweden). The
assay diluent from the ELISA kit was used as the perfusion fluid. For all experiments the sample
fluid contained 2000 pg/ml IFN-γ/assay diluent. A control was run simultaneously, containing
only assay diluent. Sample fluid was collected every hour for measurement to assure the
cytokine concentration stayed constant. For the Heparin experiments, flow rates of 2μL/min and
1μL/min were used. The perfusion fluid contained 10μM Heparin. A volume of 120μL was
collected for analysis. For the antibody experiments the ELISA biotinylated anti-rat monoclonal
detection antibody was used in the perfusion fluid (1.6 nM). A flow rate of 1μL/min was used.
A volume of 125μL was collected for analysis.
ELISA
For both experiments IFN-γ concentrations were determined using the ELISA kit. The samples
were analyzed with a Tecan Infinite M200 multifunctional microplate reader (Tecan Group
Mänedorf, Switzerland). Fluorescent absorbance was measured at 450nm and subtracted at
570nm. The Heparin experiment samples were analyzed according to the ELISA protocol by
BD Pharmigen. The detection antibody samples were analyzed using a modified ELISA
procedure. In the modified procedure the cytokine samples were prepared and incubated with
detection antibody before being added to the microwells as opposed to the standard protocol,
which requires addition of the antibody after the samples have incubated in the microwells.

Results and Discussion
Heparin Samples
Different concentrations of Heparin were added to standard IFN-γ to test for interference with
the ELISA assay. The graph is presented in Figure 1. Heparin concentrations up to 10μM appear
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to not interfere with the assay. Microdialysis samples with heparin in the perfusion fluid were
collected at two flow rates and analyzed. The relative recovery is presented in Figure 2. As
expected the microdialysis yielded a small relative recovery. The heparin added to the perfusion
fluid did not appear to increase RR. This may be due to the binding kinetics of heparin and IFNγ.
Detection Antibody Samples
Detection antibody was incubated with IFN-γ at different time periods to test for interference
with the ELISA assay. The graph is presented in Figure 3. Only the twelve hour incubation time
appeared to significantly affect the assay. Microdialysis samples with antibody in the perfusion
fluid were collected over two different time intervals and were analyzed. The relative recovery
is presented in Figure 4. For the two hour collection time, the antibody sample had too low of an
absorbance. The control sample yielded a similar result to the heparin control. At the four hour
collection time, the antibody sample did have absorbance, but did not significantly increase RR.
Because this is a modified ELISA procedure, the incubation or concentration of antibody may
need to be adjusted.

Conclusion
Interferon-γ microdialysis samples were successfully collected using affinity agents. Both
heparin and the detection antibody did not show interference with the ELISA procedure, which is
used to analyze the samples. Though they do not interfere, the affinity agents do not appear to
significantly increase the relative recovery of the IFN-γ. Interestingly, the detection antibody
method could be a viable way to collect cytokine. Since the antibody is used in the ELISA
procedure, it could lead to cost effective ways to collect and analyze cytokines. In future work
different cytokines may be tested with these procedures.
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Figure 1: Log-Log graph of Interferon-γ and varying concentrations of heparin.
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Figure 2: Microdialysis relative recovery of Interferon-γ with heparin.
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IFN-γ Detection Antibody Incubation Dependence
0.4

Absorbance (nm)

-0.1 1.4

1.6

1.8

2

2.2

2.4

2.6

2.8

3

3.2

-0.6

1 Hour
4 Hours
13 Hours
-1.1

-1.6

Concentration (pg/mL)

Figure 3: Log-Log graph of Interferon-γ incubated with detection antibody at different time
periods.
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Figure 4: Microdialysis relative recovery of Interferon-γ with detection antibody.
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Enhanced Recovery of Cytokines in vitro: A Microdialysis Study
William Newhart, Missouri Western State University
St. Joseph, Missouri

Abstract
Microdialysis is a well known sampling method that uses concepts of simple diffusion to
extract analyte concentrations from various tissues of a living organism. Recent studies
using this sampling technique have focused on quantifying signaling proteins called
cytokines, but have had little success due to the cytokines low diffusion coefficient and
concentration in vivo. The purpose of this study was to analyze heparin for its ability to
increase the RR of selected cytokines in vitro and interfere with the quantification of such
cytokines with ELISA protocols. Heparin is a naturally found polysaccharide that has a
high binding affinity to many types of cytokines. In this study, the relative recovery of the
cytokine MCP-1 was shown to increase with heparin concentration, but possible
interference by heparin of the ELISA analysis was observed. Cytokine RANTES was
shown to possibly display high dose hook effect with a modified ELISA protocol. A
significant difference in dialysate collected between 0% and 1% BSA was also observed in
an independent assay.

Introduction
Microdialysis is a well known sampling method that uses concepts of simple diffusion to
extract analyte concentrations from various tissues of a living organism. The principle procedure
in any microdialysis study involves pumping a perfusion fluid through a semi-permeable probe
that is placed in tissue or solution. In theory, higher analyte concentration on the outside of the
probe causes diffusion of the analyte through the probe via pores with a molecular weight
restriction. Sample fluid collected, called dialysate, is then pumped out into a collection vessel
for further investigation.1 Normally, effective removal of the of the analyte from the sample
media is described in terms of it’s extraction efficiency (EE), expressed as the following
equation below, where C d , C e , and C i are the concentration of the analyte in the dialysate,
sample media, and perfusion fluid respectively.2
EE = (C d – C i ) / (C e - C i )

(1)

If C i = 0, then the EE is referred to as the relative recovery (RR).2
Since its modern conception in the early 1980’s, microdialysis has been used to
investigate the concentration of neurotransmitters and small molecules such as dopamine,
acetylcholine, noradrenalin, and glucose in vivo. The method has been used in conjunction with
separation and detection instrumentation such as liquid chromatography, capillary
electrophoresis, and currently with positron emission tomography (PET) for aiding in
validation.3 In recent years, the technique has focused on sampling various types of proteins in
living tissue.4 These molecules have posed significant problems to the sampling techniques
because of their relatively low concentrations in-vivo and their low diffusion coefficients through
tissue.4 Factors including molecular weight, ionic charge, and hydrophobic interactions also
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amplify the difficulties of sampling with a semi-permeable membrane probe of set molecular
weight cutoff (MWCO).4 Then there are the difficulties of probe design, calibration, and wound
response in vivo that encapsulates the probe, thus hindering accurate collection over a long
periods of time.2 A specific classification of proteins called cytokines are of particular interest to
the microdialysis community. These proteins are especially important for study because they are
responsible for communicating and signaling a wide variety of responses relating to immunity,
wound healing, and cell differentiation.5
A current approach to increasing the RR of cytokines in vitro and vivo has been the
application of chemical agents that bind or alter the analyte passing into the probe so that it
cannot diffuse back into the media. Current attempts have included using microbeads bound with
antibodies specific to a single cytokine with flow cytometer detection.5 However, saturation of
the capture sites on the beads has lead to investigating the use of more non-specific, cost
effective agents. One such agent has been the use of heparin. This repeating polysaccharide binds
very well to variety of cytokines and is relatively inexpensive to obtain, making it an ideal
candidate for studying cytokine detection in vivo.6
The purpose of this study was to analyze heparin for its ability to increase the RR of
selected cytokines in vitro and interfere with the quantification of such cytokines with ELISA
protocols. For this study monocyte chemoattractant protein (MCP-1) and Regulated upon
Activation, Normal T-cell Expressed Secretion (RANTES) protein was analyzed with heparin.
MCP-1 is a homodimer that activates several types of nonspecific and specific immune
cells.7 The relevance of quantifying MCP-1 grows when considering it has been supported to
help in the hardening of arteries in mice with high cholesterol.7 RANTES, also a homodimer and
activator of immune cells, has been studied to share a common protein receptor for HIV-1
infection.8 Being able to accurately quantify these cytokines could give key diagnostic markers
for particular cell infections and pathologies.

Experimental Procedures
BSA Flow Rate Assay
Bovine Serum Albumin (BSA, Sigma Aldrich) was prepared to concentrations of 1 to 4%
in phosphate buffered saline (PBS, 100 mM, pH 7.4). After overnight equilibration of solution at
4 0 C, BAS microdialysis pump with self-assembled triple syringe bracket was used to perfuse
500 uL of each respective BSA solution through a CMA-20 14/10 PES microdialysis cannula
probe (CMA, Stockholm, Sweden 100 kDa MWCO) that was submerged in 1 mL of sample
media consisting of the same composition as the perfusion fluid. Dialysate collection vials were
massed before and after sampling and were kept at the same height on the lab bench as the
sample media vials and syringes. Probes were flushed before assay with distilled water for 30
minutes at 3 µL/min using 1000 µL BAS glass syringes. BSA solutions were allowed to flush
through probes after flushing with water for 20 minutes at 2 µL/min to flush probes with
experiment’s perfusion fluids. Three trials apiece were conducted for each BSA concentration
for 1 hour at 2.0 µL/min. Room temperature was recorded at 230. Control assays were performed
three times with the same PBS solvent with the same parameters. Density of each BSA solution
was performed via massing 1.00 mL aliquots into unused, pre-massed centrifuge tubes. Three
density values were calculated per BSA solution and an average was calculated. The average
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density was used to solve for the average volume of each individual trial per BSA solution.
Average volume with error was then calculated for each solution and control and a percent
recovered volume was calculated based on the theoretical volume of solution pipetted. ANOVA
single factor t-test at 95% confidence was performed for all BSA together and only for 1%, 2%,
and 4% BSA.
Heparin Interference Assay with MCP-1
ELISA protocol from BD Pharmingen (BD Biosciences, San Diego, CA) was used to run
control and spiked MCP-1 standards. Heparin sodium salt from porcine intestinal mucosa (Sigma
Aldrich, H3149) was used to create 20µg/mL, 0.2µg/mL, and 0.002µg/mL heparin solutions
dissolved in assay diluent as ordered from BD Pharmingen (10% FBS in PBS: 80g NaCl, 11.6g
Na 2 HPO 4 , 2.0g KH 2 PO 4 , 2.0g KCl, q.s. to 10 L; pH to 7.0). ELISA protocol followed according
to BD. Heparin samples added to wells in 50 µL amounts to 50 µL of appropriate MCP-1
prepared standards so that final volume was protocol recommended 100 µL per well and that the
MCP-1 standard and heparin were at the desired concentrations. All controls (no heparin added)
and spiked standards were run in duplicate. Standards made as recommended from 1000-31.25
pg/mL via serial dilution. BD Falcon 96 well flat bottom transparent plate used for assay was
read via Infinite Optical Scanner for Absorbance at 450 nm with a 570 nm recommended
reference. Standard curves were generated according to BD ELISA protocol for all samples and
slopes were compared to the control standard.
MCP-1 Microdialysis with Heparin
MCP-1 sample media (2000 pg/mL, BD Pharmingen) was prepared according to protocol
recommendations in prescribed assay diluent. BAS microdialysis pump used with 3 syringe
bracket to perfuse either 0, 1, or 10 µM heparin concentrations prepared in BD assay diluent.
One syringe was used per heparin concentration and 3 trials were conducted per perfusion fluid
at 1.0 µL/min until a total volume of 390 uL was collected altogether. 300 µL of sample media
was taken before and 300 µL of media was taken after each heparin solution was perfused
through the probe. Dialysate collected was kept on ice while sampling and both dialysate and
sample media vials were covered with parafilm during the sampling. Heparin solutions were
prepared from stock (1009 µg/mL) prepared by dissolving massed amount of Heparin sodium
salt from porcine intestinal mucosa (Sigma Aldrich, H3149) in BD assay diluent. The molecular
weight of the heparin was taken from reported literature values to be 12,000 g/mol. CMA probes
used for the BSA assay were used and flushed with BD assay diluent at 2.0 µL/min for ~20
minutes before sampling. Samples were collected and stored at 4oC overnight.
Samples were quantified via MCP-1 ELISA protocol from BD Pharmingen on a BD
Falcon 96 well flat bottom transparent plate. 2000 pg/mL standard prepared for the microdialysis
sampling was used to prepare all ELISA standards serially diluted according to protocol (100031.25 pg/mL). Standards were run in duplicate and spiked standards were prepared in the same
manner as referred in the MCP-1 interference assay but using 20, and 2 µM prepared heparin
solutions from 1009 µg/mL stock. Sample media before microdialysis and sample media
perfused with control (0 µM heparin) was run only a single time due to plate size restrictions. All
other dialysate and sample media after microdialysis were run in duplicate. Standard curves were
generated for each heparin concentration according to BD Pharmingen protocol. Regression lines
were used to calculate RR for the average dialysate concentration calculated from the absorbance
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values. Sample media concentrations before and after microdialysis sampling were averaged to
generate an average media concentration used to calculate percent RR. Averages and standard
deviations were also calculated for each RR.
RANTES Interference Assay with Heparin
ELISA protocol from Preprotech (PREPROTECH, Inc., New Jersey) was used to run
control and spiked RANTES standards. Heparin sodium salt from porcine intestinal mucosa
(Sigma Aldrich, H3149) was used to create 20µg/mL, 0.2µg/mL, and 0.002µg/mL heparin
solutions dissolved in assay diluent as ordered from BD Pharmingen. ELISA protocol modified
from Preprotech in that assay diluent from BD was used in steps to block wells, add standards,
samples, detection antibody, Avidin-HRP Conjugate, and using BD substrate solution to measure
absorbance. Addition and incubation of BD substrate and stop solutions were followed according
to BD protocol for the first two assays due to lack of Preprotech reagents prescribed. Third assay
modified by using recommended diluent for standard and sample addition via preparation the
day of assay (0.05% Tween-20, 0.1% BSA, in PBS) and substrate incubation time was modified
from 30 minutes (BD prescribed) to stopping reaction upon observation of homogeneous color
over the well plate. Heparin solutions added to wells with RANTES standards so that final
volume was 100 µL and both RANTES and heparin were at desired concentrations. All controls
(no heparin added) and spiked standards were run in duplicate. Standards made as recommended
from 1000-31.25 pg/mL via serial dilution. BD Falcon 96 well flat bottom transparent plate used
for assay was read via Infinite Optical Scanner for Absorbance at 450 nm with a 570 nm
reference as advised by the BD protocol when using BD substrate solution. Standard curves were
generated according to BD ELISA protocol for all samples and compared to the control standard.

Results and Discussion
BSA Flow Rate Assay
In microdialysis sampling, addition of BSA to perfusion fluid is a way to decrease of the
effect of ultrafiltration, where fluid loss occurs due to hydrostatic pressure.1 This fluid loss will
lower dialysate volume and give inaccurate measurements to the recovered dialysate. BSA also
functions to hinder non-specific adsorption of the cytokines to the inner lining of the tubing.
Table 1 shows the average volume recovered from each microdialysis probe perfused with a
single BSA concentration through a sample media of that same concentration. Single factor
ANOVA gave F-values for 0, 1, 2, and 4% BSA recovered volumes to be 6.41 with F critical =
4.07. ANOVA for the comparison of 1, 2 and 4% BSA average recovered volumes gave F = 2.85
and F critical = 5.14. These F values support that there is a significant difference in the average
recovered volume of BSA solution between 0% BSA and 1%, 2%, and 4% BSA. Error in the
pump’s calibration was deemed not significant after two assays with three trials each (data not
shown).
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Percent BSA

Avg. vol.
in uL (n=3)

Standard
Deviation

0%

100.54

0.0099950

1%

116.27

0.0029800

2%

113.58

0.0025900

4%

116.87

0.0017010

Table 1 - Average volume and standard deviation of dialysate collected after microdialysis perfusion of PES probes
with stated percent concentrations of BSA in prepared PBS. Assays were run at 2.0 µL/min for 60 minutes. Actual
volumes per trial calculated from average density (n=3) with respective BSA concentrations. Underlined values
denote BSA concentration giving significant difference when compared via single factor ANOVA using Microsoft
Excel®

Heparin Interference Assay with MCP-1
It was an important aspect of this study to observe if heparin did interfere with the
cytokine quantification via ELISA. The three cytokine concentrations tested were based on what
is normally a high to low range of heparin perfused through a microdialysis probe. Upon
observation of Figure 1, all spiked heparin standards seem to deviate from the control curve at
the lower MCP-1 concentrations (125-31.25 pg/mL). Addition of the substrate solution to the
wells could be a factor to the deviation of the standard curves. A single tip pipette was used to
add the 100 µL of substrate solution to each of the 56 wells used. The substrate could have
longer times to bind to the detection antibody in wells pipetted first with substrate as opposed to
wells pipetted last. This could vary the intensity of the absorbance of the assay and misrepresent
the results. A statistical test in the error of each sample and control curve would need to be
performed to give more certainty to the observed results.
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Heparin/MCP-1 Interference Assay
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Figure 1 – Log-log plot of absorbance versus of concentration of rat MCP-1 in ELISA assay to analyze for Heparin
interference. Regression line refers to correlation of standard curve only. All other points refer to ELISA samples
prepared to the same concentration as the standards, and with the labeled amount of Heparin sodium salt.
Concentrations were 1000, 500, 250, 125, 62.5, and 31.25 pg/mL rat MCP-1 serially diluted from a 2000 pg/mL
prepared stock.

Heparin Concentration (µg/mL)
0.0
0.001

Slopes
0.6874
0.7164

0.1
10

0.6813
0.5404

Table 2- Slopes of Log-Log Regression Lines generated by Microsoft Excel® for standard curves of MCP-1 ELISA
with spiked standards of heparin. All standard curves were run in duplicate and their absorbance values were
averaged before plotting according to the BD protocol.

MCP-1 Microdialysis with Heparin
The absorbance values for the 0, 1, and 10 µM heparin perfused dialysate was
0.1501 +/- 0.003041, 0.2926 +/- 0.0969, and 0.1968 +/- 0.003645 respectively, n = 2 for all.
Average concentrations for the sample medias before and after was 1261.0 +/- 71, 1110.5 +/284, and 1104.0 +/- 293 pg/mL (n = 2) respectively for 0, 1, and 10 µM heparin solutions. These
values gave percent relative recoveries of 8.41%, 18.34% and 21.20% respectively for 0, 1, and
10 µM heparin dialysate samples, as graphically illustrated in Figure 2. While these percent RR’s
indicate that heparin increased recovery, several factors come into consideration for the data.
First, sampling media taken before microdialysis was analyzed one time on the ELISA due to
plate size restrictions of fitting all necessary samples and standards. Normal standards and
samples are run at least twice to obtain a more accurate average value. The time of microdialysis
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Relative Recovery %

sampling also came into question for error analysis. As previously stated, cytokines different
chemical properties like hydrophobicity, and molecular weight cause problems for their
sampling.4 A large factor of microdialysis sampling relies on flowing perfusion fluid at a high
enough rate for a long enough time to attain an accurate representative sample of the solution or
tissue. Another factor is the assay diluent itself contained fetal bovine serum (FBS), which has
not had all its components separated and analyzed. There is a possibility that there are several
proteins in the diluent that could also bind to the heparin and hinder MCP-1 from binding to the
unbound heparin. Then there is the error associated with the ELISA itself. Normal allowable
error in any immunological assay ranges from 15-20%. The percent RR was already low relative
to the sample media’s initial concentration, thus any error in the normal range of the ELISA
would misrepresent the recovery.

0 µM Heparin
1 µM Heparin
10 µM
Heparin

Heparin Concentration (µM)
Figure 2 - Relative Recovery of MCP-1 in vitro microdialysis sampling with different concentrations of heparin in
perfusion fluid. Samples analyzed via ELISA protocol by BD Pharmingen. Linear regression equations per spiked
set of standards used to calculate relative recovery. Dialysate samples trials run in duplicate on the plate. Sample
media of each concentration run as a single well due to plate size restrictions. Percent RR for 0 µM, 1µM, and 10
µM respectively were 8.41%, 18.34% and 21.20%

RANTES Interference Assay with Heparin
As with the MCP-1 ELISA, heparin could also interfere with the chemical analysis of
RANTES. The ELISA for RANTES was performed on three separate occasions due to control
and sample standards giving absorbance values that were over detection limits of
instrumentation. Assay I (Figure 3a) gave over detectable absorbance values for all 1000, and
500 pg/mL standards, as well as all but three 250 pg/mL standards which were for 0.1 and 0.001
µg/mL heparin standards. There was only a single absorbance value for the 250 pg/mL standard
run for the 0.1 µg/mL heparin, so an average absorbance could not be calculated, thus
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contributing error. Assay II (Figure 3b) gave over ranged values for all 1000 and 500 pg/mL
standards, including controls. Assay III (Figure 3c) gave only one well at 250 pg/mL spiked with
0.1 µg/mL heparin over the detection range. The log-log plots of the standards that were
detectable for Assay I and II appear to follow the standard curve. Assay III however appears to
give a “hooking” pattern to the standards as the RANTES concentration increases. This
observation is similar to the observed “Hooking” effect in ELISAs. This phenomenon occurs
when high analyte concentration decreases the slope of the standard curve prepared (i.e. high
dose hook effect).9 However, this effect was studied to be more prevalent in one-step ELISAs,
where capture and detection antibodies are mixed with the analyte.9 The ELISA protocol used
was a modified version for Assays I-II due to lack of recommended reagents. The recommended
assay diluent was prepared for Assay III for locating the primary error in the standards. While an
increase in number of detectable standards was noticed, the adding of the substrate solution to
bind to the detection antibody may be another significant error. The BD Pharmingen substrate
was not prescribed by Preprotech for this ELISA. High concentrated standards began reacting
with the substrate within seconds after substrate addition. This was also observed in Assays I and
II. The 30 minute incubation time recommended by BD for the substrate may react too quickly
for RANTES. The shortened incubation time for Assay III was prescribed by the Preprotech
protocol, which specified monitoring the reaction until a homogeneous color was observed over
the plate. Incubating substrates for long periods of time would produce absorbance values over
the detection limit of the instrumentation, especially for high concentration standards.
Heparin Interference with RANTES: Assay I
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Figure 3A
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Heparin Interfernce with RANTES: Assay II
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log of Absorbance (450 nm)

Heparin Interference with RANTES: Assay III
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Figure 3C
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Heparin Standards
(µg/mL)
Assay I

Assay II

Assay III

Slope

0
0.001
0.1
10

1.1771
1.0789
1.0401
1.188

0
0.001
0.1
10

0.8554
0.9246
0.9389
0.9551

0
0.001
0.1
10

0.5087
0.4972
0.5147
0.5389

Figure 3D

Figures 3A,B,C, D – Log-log plot of absorbance versus of concentration of rat RANTES in ELISA assays I-III to
analyze for Heparin interference (A-C). Regression line refers to correlation of standard curve only with no heparin.
All other points refer to ELISA samples prepared to the same concentration as the standards, and with the labeled
amount of Heparin sodium salt. Standards plotted for Assay I were 125-31.25 pg/mL for all standards and 250-31.25
pg/mL for 0.1 and 0.001 µg/mL spiked standards. Standards for Assay II plotted were 125-31.3 pg/mL
Concentrations of Assay III were 1000, 500, 250, 125, 62.5, and 31.25 pg/mL rat RANTES serially diluted from a
2000 pg/mL prepared stock. (D) Table of each assay’s regression line slope.

Conclusion
In analyzing BSA concentration versus flow rate, there was an observed significant
difference in perfusing 0% and at least 1% BSA. There was also possible interference of the
MCP-1 ELISA by BD Pharmingen with Heparin at low standard concentrations. Microdialysis
of MCP-1 showed an increase in Relative Recovery as heparin in perfusion fluid increased.
Possible hook effect also observed with the modified ELISA protocol of RANTES with heparin.
Statistical analysis of error in standard curves would be a necessary step in giving certainty to
results with heparin interference.
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Exploratory Hierarchical Nanomachining of New Tertiary HeteroMicro/Nanostructures of ZnO
Sean Nomoto, University of Wisconsin-River Falls
River Falls, WI

Abstract
In this systematic exploration to synthesize tertiary nanostructures, primary microrods
were made and used as substrates to produce secondary nanobranches, and the secondary
growth was used as a substrate with increasing concentrations of 1, 3-diaminopropane
(DAP) for tertiary nanobranches in order to determine the behavioral growth and
appearance of the tertiary nanobranches. A concentration of ~120-140mM DAP in the
tertiary synthesis yields an interesting type of nanobranch that gives the overall structure a
cactus-like appearance.

Introduction
Zinc oxide has been studied extensively for its different structural growths that occur
during hierarchical synthesis. Zinc oxide has semiconducting properties with a wide band gap of
3.37eV,1 and it has physical properties, strongly related to structural properties, that are worthwhile investigating so that many of the applications and devices utilizing ZnO can be better
studied.2, 3 Some of the applications of interest are gas sensing,4 photon detection,5 light emitting
devices (LEDs),6 transistors,7 and photocatalysis.8

Structure
The primary growth of the zinc oxide micro-rods is a crystallization of zinc oxide
molecules that tend to favor a directional growth in the <0001> direction which is the direction
normal to the plane of the base of the crystal.9 There also exists growth in the other directions
but they grow at different rates. The rates of growth for the directions are, ranked from highest
to lowest: <0001>, <0110>, <0001>.9 Figure 2, from Li, et al, below on the left shows the
directional growth of the hexagonal crystal.9 In Figure 2, the scanning electron microscopy
(SEM) image on the right from Tierui, et al shows the primary ZnO growth.1

Figure 2. On the left, the directional growths of zinc oxide are shown in this figure from Li, et
al.9 On the right, SEM image of a ZnO primary rod from Tierui, et al.1
The primary micro-rod structure was demonstrated to have a hexagonal wurtzite structure
as shown in Figure 1 above, and it has also been determined by X-ray diffraction (XRD) (P6 3 mc,
a=3.2495 angstroms, c=5.2069 angstroms).2 The zinc oxide crystals are polar, and the overall
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structure is such that the top planes of the crystal are mostly polar planes of zinc with faster rates
of growth while the bottom plane is non-polar and composed of oxygen with the slowest rates of
growth.10

Synthesis of Hierarchical Structures
The reactions that form ZnO are between zinc nitrate and hexamethylenetetramine
(HMT) in a water solution. The HMT becomes protonated by the water and reacts with zinc
ions, and the zinc hydroxide is formed from the Zn+2 reacting with H 2 O and further hydrolysis
yields zinc oxide. The zinc hydroxide can be hydrolyzed by the protonated HMT to produce
zinc oxide. Figure 1 below, from Yanhong Tong, et al, shows the reaction mechanism by which
the zinc oxide is yielded.10

Figure 1. The reaction mechanism with zinc nitrate and HMT shown in the equations from
Tong, et al.10
In addition to the primary synthesis of ZnO, adding some diaminoalkanes to the reaction
solution of HMT and zinc nitrate can cause further growth of nanobranches using the primary
micro-rods as the substrate.11 In particular, 1, 3-propanediamine (DAP) has been used to study
the systematic secondary growth and nucleation of ZnO.11 In Figure 3 shows the SEM image of
the secondary growth of ZnO nanobranches.

Figure 3. An SEM image of secondary nano-branches on a
microrod from Tierui, et al
is shown.1
The nucleation of the secondary branches is dependent
on a lower limit and an upper limit of DAP concentration.11
The lower limit, the critical nucleation concentration (CNC),11
describes the minimum concentration for nucleation to occur, and the upper limit is the limit of
the zinc oxide solubility.11 Mae, et al describes the multiple effects of diaminoalkane molecules
added to the reaction. In addition the effects of molecules, such as zinc-amino complexes and
increasing pH, the group has also shown that the secondary crystals on the primary substrate also
have a hexagonal wurtzite shape as seen in SEM images.
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The mechanism of secondary nucleation is not well understood, but Mae, et al believes
that small holes, edges, and defect sites on (1010) facets of zinc oxide crystals serve as
nucleation sites for secondary growth.11 Once the crystallization starts, crystals grow outward in
a radial pattern to show six branches for each facet on the primary substrate. The growth pattern
of the secondary branches has been observed to first grow short branches with a greater density
distribution, and as the concentration of DAP rises, the branches become longer and the density
distribution decreases.11 According to Zhang, et al, concentrations of approximately 140mM will
only cause the primary structures to increase in size to take the shape of a large pencil tip.
Tertiary growth has not been extensively studied with DAP, but it has been investigated
using other dimaminoalkanes. A controlled synthesis of tertiary structures with butanediamine
(DAB) has been well studied,12 and below in Figure 4, a tertiary structure produced with DAB is
shown from Liu, et al.12

Figure 4. On the right, a tertiary structure synthesized with the
diaminoalkane DAB is shown, from Liu, et al.12

Experimental Procedures
A total of 54 ZnO primary microrods were synthesized by heating 54 ~15mL Teflon
bottles with 10mL aqueous solutions of 20mM Zn(NO 3 ) 2 and 20mM HMT in a drying oven for
17 hrs at 60°C. To each Teflon bottle, a ~0.5 x 3 cm, clean piece of a microslide glass was
added. To glass substrates were cleaned by allowing them to soak in 2M HCl, then rinsing them
with water, and drying them in an oven. After the reaction was completed, the glass substrates
were carefully washed and dried. The morphology of the ZnO was determined by SEM. Of the
54 primary substrates, a set of 6 secondary structures were prepared by the identical method for
the primary rods except for the following: DAP was added in increasing amounts of 90, 95, and
100µL, and the reaction was heated at 60°C for 4 hrs. The morphology was analyzed by SEM.
Another set of 5 secondary structures were made by the same procedure except the increasing
amounts of the 98% DAP were 105, 110, 115, 120, and 125µL. A set of 21 secondary structures
were prepared by the same procedure except all had 100µL of DAP. Of the 21 secondary
structures made with 100µL DAP, 6 were used to synthesize tertiary structures by the same
method except the increasing amounts of 98% DAP were 70, 80, 90, 100, 110, and 120µL. The
samples were coated with Au by a sputter coater and analyzed by SEM. A second set of tertiary
structures were prepared by the exact same procedure with no exceptions. The second set was
also analyzed by SEM.
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Results and Discussion
The SEM images of the sets of the tertiary synthesis showed that the growth occurred at
70 µL of DAP, and then for the amounts between ~80-100 µL of DAP, unusual morphology of
the tertiary began to appear. Most of the tertiary growth appeared randomized about the center
of the primary rod structure and about the secondary branches as well. SEM images of samples
with ~70 µL DAP are shown below in Figure 5, and these particular nanocrystals appear to be a
state at which they are not fully developed.
(a)

(b)

(c)

(d)

d

Figure 5
Figure 5 (a) and (b) were synthesized in10 mL solutions of 20mM Zn(NO 3 ) 2 , 20 mM
HMT, and ~70 µL DAP heated at 60°C for 4 hrs. These structures show little development in
tertiary growth. Whereas, in Figure 5 (c) and (d), prepared by the same procedure, show a state
of growth that is much more developed.
Contrary to the DAB tertiary growth, the DAP growth appear in needle-like branches,
characteristic of the secondary growth with DAP. Most structures appeared somewhat as
expected, but with the higher amounts of DAP, the needle-like branches became larger in some
cases while some needle-like branches remained small. The most unusual structure obtained was
a cactus-like structure that had tertiary growth on the top of the primary structure and on the tips
of the secondary branches. Figure 6 below shows the tertiary growth at the higher concentration
of ~120-140mM DAP. This morphology occurred twice at high concentrations of DAP,
volumes of 110 and 120 µL of 98% DAP.

52

(a)

(b)

(c)

(d)

Figure 6
Figure 6 (a), (b), (c), and (d) were prepared by the same method as the structures in
Figure 5 except the volumes of DAP added were ~110-120 µL. In Figure 6 (a), the tertiary
growth appears to change into sparse, randomized nanobranches. Figure 6 (b) shows
nanobranches spreading outward onto the secondary microbranches, and then (c) shows the
nanobranches growing on just the tips of the secondary microbranches. Finally, in (d), the
tertiary growth is shown exclusively on the ends of all the microbranches.

Conclusion
The growth habit of the ZnO tertiary structure may follow a trend of some form of
regularity, but the morphology is not well understood. More work must be done on the effect
pH, time, temperature, ratios of amounts, etc., and work must also be done to study the physical
properties of the new morphologies.

Acknowledgements
I would like to thank the Dept. of Chemistry and Biochemistry at the University of
Arkansas and Dr. David Paul. I would also like to thank the National Science Foundation CHE0552947/REU.

References
1. Zhang, Tierui; Dong, Wenjun; Keeter-Brewer, Mary; Sanjit, Konar; Njabon, Roland N.;
Tian, Z. Ryan. Site-Specific Nucleation and Growth Kinetic in Hierarchical
Nanosyntheses of Branched ZnO Crystallites. J. Am. Chem. Soc. (2006),128(33), 1096010968
53

2. Tian, Zhengrong R.; Voigt, James A.; Liu, Jun; Mckenzie, Bonnie; Mcdermott, Matthew
J.; Rodriguez, Mark A.; Konishi, Hiromi; Xu, Huifang. Complex and oriented ZnO
nanostructures. Nat. Mater. (2003), 2(12), 821-826
3. Look, D. C. Recent advances in ZnO materials and devices. Mater. Sci. & Eng., B:
Solid-State Mater. for Adv. Tech. (2001), B80(1-3), 383-387
4. Dixit, Shobhna; Srivastava, Anchal; Srivastava, Atul; Shukla, R. K. Effect of toxic gases
on humidity sensing property of nanocrystalline ZnO film. J. Appl. Phys. (2007),
102(11), 113114
5. Ohta, H.; Hirano, M.; Nakahara, K.; Maruta, H.; Tanabe, T.; Kamiya, M.; Kamiya, T.;
Hosono, H. Fabrication and photoresponse of a pn-heterojunction diode composed of
transparent oxide semiconductors, p-NiO and n-ZnO. Appl. Phys. Lett. (2003), 83, 1029
6. Alivov, Y. I.; Van Nostrand, J. E.; Look, D. C.; Chukichev, M. V.; Ataev, B. M.
Observation of 430 nm electroluminescence from ZnO/GaN heterojunction light-emitting
diodes. Appl. Phys. Lett. (2003), 83, 2943
7. Li, Chen Sha; Li, Yu Ning; Wu, Yi Liang; Ong, Beng S.; Loutfy, Rafik O. Performance
improvement for solution-processed high-mobility ZnO thin-film transistors. J. Phys. D
Appl. Phys. (2008), 41(12), 125102
8. Yang, Jia Long; An, Sung Jin; Park, Won Il; Yi, Gyu-Chul; Choi, Wonyong.
Photocatalysis using ZnO thin films and nanoneedles grown by metal-organic chemical
vapor deposition. Adv. Mater. (2004), 16(18), 1661-1664.
9. Li, Wen-Jun; Shi, Er-Wei; Zhong, Wei-Zhuo; Yin, Zhi-Wen. Growth mechanism and
growth habit of oxide crystals. J. Crystal Growth (1999), 203(1/2), 186-196
10. Tong, Yanhong; Liu, Yichun; Dong, Lin; Zhao, Dongxu; Zhang, Jiying; Lu, Youming;
Shen, Dezhen; Fan, Xiwu. Growth of ZnO Nanostructure with Different Morphologies
by Using Hydrothermal Technique. J. Phys. Chem. B (2006), 110(41), 20263-20267
11. Sounart, Thomas L.; Liu, Jun; Voigt, James A.; Huo, Mae; Spoerke, Erik D.; McKenzie,
Bonnie. Secondary Nucleation and Growth of ZnO. J. Am. Chem. Soc. (2007),
129(51), 15786-15793
12. Sounart, Thomas L.; Liu, Jun; Voigt, James A.; Hsu, Julia W. P.; Spoerke, Erik D.; Tian,
Zheng; Jiang, Yingbing. Sequential nucleation and growth of complex nanostructured
films. Adv. Functional Mater. (2006), 16(3), 335-344

54

Preliminary Characterization of the Binding of an Important Ras GTPase
Binding Effector for Abnormal Cell Signaling Mutants
of the Ras Protein Cdc42
Nikita Patton, Bennett College for Women
Greensboro, North Carolina

Introduction
Cell division cycle (Cdc42) is a GTPase protein in the
Ras Superfamily. Ras proteins are responsible for
regulating cell growth and cytoskeleton organization
and Ras mutants are likely to be found in many
different cancer type cells.1 Cdc42-GTP is the active
state (GTP), Cdc42-GDP is its inactive state. When the
Cdc42 begins to act in an overactive state, this leads to
cell transformation. p21 activated kinase (PAK) is one
an effector protein that interacts with Cdc42. Forty six
amino acids of PAK known as
Protein Binding Domain 46
(PBD46) interacts with Cdc42
to control its intake of GTP.3 4
Adams, PD
PBD46 contains the CRIB
1ees.pdb
Giazchew D, Oswald RE
binding domain which is about 12 essential amino acids that directly
Biochemistry 39: 39633971
interact with Cdc42. When a mutation occurs in Cdc42 at position 28
where the phenylalanine amino acid is changed to leucine, the GTP/GDP cycle is more rapid
which leads to cell transformation. This leads to cancer. This mutation is known as F28L. The
structure of F28L is known but its binding complex is not. The study of F28L is important
because once phenylalanine is changed to leucine, there is no longer any pi
conjugation found at site 28 which is changes the comformation of the
protein. This could lead to a series of difficulties when Cdc42 F28L interacts
with other proteins. Another mutation is referred to as ∆L8. This mutation is
when the Rho insert region, amino acids 120 to 133, have been deleted from
the protein‘s amino acid sequence. ∆L8 still allows spontaneous GTP/GDP
exchange of the protein, but does not result in cellular transformation.5
2ASE. PA, Oswald RE
Biochemistry 45: 2577-2783
Currently, the structure and function of ∆L8 is unknown.
The purpose of this experiment is to compare binding affinities of Cdc42 mutants F28L
and ∆L8 to PBD46 compared to Cdc42 WT by in vitro binding assay.

Experimental Procedures
Protein Expression:
Cells from a frozen glycerol stock were taken and used to start a 5 ml overnight culture of
Cdc42 WT, F28L, and ∆L8 in an incubator at 37˚C. Inoculate 1% in 75ml of LB media to
increase the number of cells. Cell growth and cell density (Optical Density) was checked by
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measuring absorbance with UV spectroscopy at 600nm. The optimal reading is between 0.6-0.8.
Induction of 1mM IPTG starts the growth of our protein of interest. Harvest was done with
centrifuge. Expressions of our proteins were confirmed by Western Blot (WB).
Lysis:
Sonication was done to break open the cell and release the protein into lysis buffer (1x
PBS, 10mM MgCl 2, 0.1 mg/ml of lysozyme). Samples were incubated on ice for 1 hour,
sonicated and were centrifuged at 20,000rpm for 30 minutes. The supernatant was collected to
quantify our protein. 15µl of 1+1+ solution was added to to color and detect our protein with
50µl of each cell lysate. All samples were heated at 75°C for 15 minutes to linearize the protein.
A protein gel electrophoresis was done to quantify proteins.
“Pull Down” In Vitro binding assay:
The purpose of this is to determine if Cdc42 mutants F28L and ∆L8 bind to PBD46
relative to Cdc42 WT. The cell lysate of Cdc42 WT, F28L, and ∆L8 were each tested binding to
purified PBD46. GST was used as nonspecific binding controls with Cdc42 WT, F28L, and ∆L8.
This was done to show that Cdc42 both the WT and mutants bind to PBD46 and not the GST tag.
Each sample was combined in PBS buffer and 0.5mM GMPPCP. GMPPCP is a nonhydrolyzable
analog that allows the terminal phosphate group to stay intact and not change into GDP. This
must take place in order for PBD46 to bind to Cdc42. Then al incubated at 4°C for 4 hrs. Adding
glutathione sepharose beads and incubate at 4°C for 1hr allows the bead to bind to PBD46 and
pull it down once it has binds to Cdc42.2 Beads were washed with PBS buffer. To elute, wash
with 20mM Tris 10mM glutathione buffer pH8.SDS-PAGE was then performed to visualize the
quantity of PBD46 and GST being recovered from the process.
A Western Blot was performed. In order to make the protein accessible to the antibody
detection and to immobilize the protein, transfer the gel over to the nitrocellulose membrane. The
membrane was rinsed with 5% nonfat milk to fill all the unoccupied spaces not filled with our
protein and then incubated for 20-30 minutes at room temperature. All excess milk was removed
and the membrane was rinsed three times with TBS-T buffer. Detect Cdc42 WT and mutants by
adding the first anti N-terminus-His tag that binds to the His-tag and the secondary antibody goat
anti-mouse IgG-AP. 5µl of the anti N-terminus-His tag that binds to the His-tag on the protein
was added in 5ml of 0.2% BSA and TBS-T buffer and incubated for 5 hours. Both were rinsed
with TBS-T buffer and 2.5µl of the secondary antibody goat anti-mouse IgG- AP were added in
5ml of 0.2% BSA and TBS-T buffer. Incubate overnight. Wash with TBS-T. For the enzymatic
reaction to take place and develop the membrane, 7.5ml of TBS-MgCl2 buffer was added with
25µl of BCIP and 50µl of NBT. This is done to verify that the protein that was pulled down and
shown in the gel is our protein of interest. 10% Acetic acid is used to stop the reaction once all
the protein is visible on membrane.
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Data Collection
Protein Gel Electrophoresis

Pull Down In Vitro Binding Assay

Figure 2

Figure 1

Figure 3

Results and Discussion
Figure 1 part A shows good expression levels of the Cdc42 WT and mutants. Figure 1
part B shows that expression of a protein is very sensitive to initiation of induction. If
exponential growth is very high, then the protein expression is lower. Figure 2 verifies which
bands on the gel were our proteins of interest using WB. Figure 3 shows that in the In vitro
binding assay, Cdc42 WT and mutants do bind to PBD46 and not GST tag.
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Conclusion
This is just a qualitative study that shows that Cdc42 WT and mutants do bind to PBD46
and not to the GST tag in In Vitro Binding Assay. An Optical Density reading between 0.5 and
0.8 shows good expression of protein, anything higher shows very little protein expressed.

Future Work
Optimize the expression of mutants. Figuring out the optimal induction time that
expresses more protein would be an improvement. Also, to quantify the binding parameters of
PBD46 to each Cdc42 mutant compared to the wildtype. This could be done to determine how
precisely each protein interact with each other with more detail.
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Analysis of Methionine Sulfoxide from Urinary Proteins in Relation to
Tobacco Use
Ashley Ramsey, University of Arkansas at Monticello
Monticello, Arkansas

Abstract
Methionine sulfoxide is a naturally occurring sulfone that is also caused by oxidants such
as tobacco smoke. A method was determined to measure the amount of methionine
sulfoxide in complex protein mixtures like urine and liver. Overall, the results show that
methionine is oxidized more in smokers than in nonsmokers. Once the method was
determined for the urine, it was applied to rat livers. The rats were injected with
acetaminophen and their levels of methionine sulfoxide were increased. Acetaminophen is
linked to acute liver failure and tobacco use is linked to many illnesses. These two are
linked together by the oxidation of methionine.

Introduction
Proteins are sensitive to oxidative damage and the biological effects are usually
important. Protein oxidation is proposed to contribute to the aging process because they are
found to be increased in older organisms. Methionine is one of the easiest residues to oxidize
even though it is not very common. The oxidation of methionine occurs in a wide variety of
proteins. The oxidants found in biological systems, ozone, and cigarette smoke all have been
shown to oxidize methionine in proteins and peptides. This oxidation tends to lower or even stop
the biological activity of methionine.
Oxidative stress in general is linked to the increased tendency of blood to coagulate,
although the molecular mechanism is not yet completely clear. The blood of smokers is much
more prone to clot than that of non-smokers. Cardiovascular diseases are the most common
cause of premature death in smokers.1 The most common cardiovascular diseases in smokers are
the thrombotic arterial occlusive diseases, in particular myocardial infarction (heart attack) and
stroke.
The oxidation of methionine is of major concern when proteins are used in
pharmaceuticals. Oxidation of these proteins could occur readily during storage and might alter
activity. The change in activity would be due to the alteration of the methionine. The side chain
size and geometry would be changed but the sulfoxide is also very polar and hydrophilic. There
is a large partial positive charge on the sulfur and a negative charge on the oxygen. This could
lead to changes in the stability or in the ability of the binding site to work correctly.5
"Acetaminophen toxicity is the number one cause of hospital admissions for liver failure
in the United States."2 Before the 1980s, acetaminophen was not mentioned as a cause in case
series of acute liver failure. A U.S. retrospective study from 1994 to 1996 found a 20% incidence
of acetaminophen toxicity leading to acute liver failure.4 It is thought that acetaminophen may
cause the oxidation of methioine in the liver.
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Materials and Methods
The procedure for the urine starts with a fresh sample that is taken first thing in the
morning. The sample is collected in a 500mL sealed container and put on ice until it is used. The
sample is divided into two equal amounts in the same size container. The samples are then put
into a Sorvall RC-5B Refrigerated Superspeed Centrifuge for 15 minutes. A GS-3 rotor was used
and the speed was 9,000 revolutions per minute and the temperature was 4ºC. The supernatant
from the two containers was poured together. Fifteen micro liters of the supernatant was poured
into a 50mL conical and 35mL of pure 100% ethanol was added. Another 50mL conical was
prepared with water as to balance out the centrifuge. The conical with the sample was then
cooled for 30 minutes at 4ºC. Then the conical were put back into the centrifuge in a SH-3000
rotor. The time was 15 minutes, the speed was 4,700 revolutions per minute and the temperature
was 4ºC. Afterwards, the conical were turned upside down over a paper towel to allow the
ethanol to evaporate.
Next the pellet is re-suspended in 3M methanesulfonic acid. The 3M methanesulfonic
acid (MSA) was made by adding 68.6µL of concentrated MSA to 281.4µL of autoclaved deionized distilled water (ddH 2 O). The solution was made in a 1.5mL Eppendorf tube. The MSA
solution was put into the conical and the once the pellet was dissolved, the solution was
transferred to a Peirce 10mm x 100mm 5mL vacuum hydrolysis tube. The solution was
transferred by a 10cc plastic syringe with a 200mm metal needle attached. This was also used to
remove the solution from the hydrolysis tube later. The cap of the hydrolysis tube was closed
tightly.
The hydrolysis tube was then thumped as to allow the gasses to rise to surface in the
liquid. The hydrolysis tube was then dipped into a .5L nitrogen gas container and allowed to
freeze. A slight cracking noise is heard when it is frozen. The tube is then removed and a vacuum
hose is put on to the arm of the tube. A vacuum is applied and the top of the hydrolysis tube is
loosened just enough to allow the vacuum to get into the bottom of the tube, but not enough to
allow air to be pulled in through the top. The cap is then tightened back up quickly. The tube is
then removed from the vacuum line and allowed to thaw before being put into a water bath. This
part of the procedure is called freeze-pump-thaw and is repeated five times to ensure that all the
gases have been removed.
After the freeze-pump-thaw procedure, the hydrolysis tube is put into a pre-heated heat
block for 2 hours. The temperature is 150ºC on the heat block. For a liver sample, the hydrolysis
tube is left for 3 hours. After the heat block, the same cools to room temperature and is removed
from the hydrolysis tube and put into a 50mL conical. The ddH 2 O is added to fill the conical to
35mL. The solution is then vortexed to mix it.
An ion exchange column is used in the next step. One gram of BIO-RAD AG 50W-X8
Resin (200-400 Mesh Hydrogen Form) is put into a plastic BIO-RAD Poly-Prep 0.8 x 4cm
chromatography column. The column is tapped on the lab bench to pack the resin down. Three
milliliters of ddH 2 O was injected onto the top of the column. A cap was then put onto the top of
the column and a syringe was put through the lid as to use it to push the water through the
column. Everything that was put on the column was pushed through with this technique. After
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the 3mL of water was pushed through, 3mL of .03M MSA was pushed through. Then the sample
was injected 3mL at a time until it all had been pushed through. After the sample, another 3mL
of .03M MSA was injected. All of the previous solutions were not kept. After the last 3mL of
MSA, 3mL of 2M pyridine was pushed through. All of the eluent was kept from this step. The
column was then washed out so it could be re-used.
Five micro liters of the pyridine eluent were put into an Eppendorf tube. A redry solution
was made with a 2:2:1 ratio of pure ethanol, ddH 2 0, and triethylamine (TEA). The solution was
mixed well and 10µL of it was added to the Eppendorf tube with the sample. A water blank was
also made with the redry solution and 5µL of ddH 2 0. The Eppendorf tubes were opened and
were dipped into the liquid nitrogen container until the samples were frozen. This takes between
5 and 10 seconds. This technique is called lyophilization and gets rid of the water by turning it
into a gas. The tubes were then quickly put into a Savant Speed-Vac SC110 heated centrifuge.
The centrifuge is connected to a vacuum line and pulls approximately 3mbar. The centrifuge was
turned on high heat and high speed. The samples were left in the centrifuge for 30 minutes. Once
the centrifuge has reached its top speed, the vacuum is turned on. After the 30 minutes, the
vacuum is turned off along with the centrifuge and the samples are checked to see if they are dry.
Once dry, the samples are derivatized. The derivatization solution consists of a 7:1:1:1
mixture of pure ethanol, ddH 2 O, TEA, and phenyl isothiocyanate (PITC). The solution is made
in an Eppendorf tube and vortexed to ensure it is mixed. Then 20µL of the derivatization solution
is mixed with the sample. The tube is allowed to sit for 20 minutes with the derivation solution at
room temperature. After this, the tubes are lyophilized and spun in the Speed-Vac the same as
they were in the above step. This time the centrifuge is allowed to run for 40 minutes.
After drying the second time, the samples are re-constituted in 100µL of Waters Pico-Tag
Sample Diluent. The samples were sonicated to ensure they dissolved. Once dissolved, the
samples were put into 300µL glass National Scientific inserts. The inserts were thumped to make
sure all the air was out of the bottom. The inserts were then placed into a VWR International
1mL clear shell glass vial. These were then loaded into the loading wheel of a Waters 717plus
Autosampler to undergo reverse-phase high-pressure liquid chromatography. The HPLC consists
of a Waters 600E Millipore System Controller, Waters 2996 Photodiode Array Detector, and a
Waters 717plus Autosampler. HPLC-grade acetonitrile (MeCN) and ddH 2 O were each mixed
with 0.1% trifluoroacetic acid (TFA) and used as eluents with a Phenomenex Jupiter Proteo
250mm x 4.60mm column. The column was heated to 38ºC. Ten micro liters was injected of
each sample. The method that was used was Atlantis TM 28FEB08. The method is shown below.
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Time
----2.0
20.00
20.50
21.50
22.50
25.00
26.00
27.00

Flow Rate
(mL/min)
1.0
1.0
1.0
1.0
1.0
1.5
1.5
1.5
1.0

%ddH 2 O

%MeCN

100
65
54
0
0
0
0
100
100

0
35
46
100
100
100
100
0
0

The standards that were used all underwent the drying and derivatization procedure that
is listed above. The standards that were made were the water blank, amino acid standard,
methionine standard, methionine sulfoxide standard, and a 5:1 amino acid/methionine sulfoxide
standard. The water blank was only 5µL of ddH 2 O and then the redry solution. The amino acid
standard was 5µL of Peirce Amino Acid Standard H and the redry solution. The methionine
standard was made to be 100nmol. To get this molarity, 14.9 mg of 99% pure methionine was
added to 1mL of ddH 2 O and vortexed. Twenty micro liters of this solution was then transferred
to an Eppendorf tube and 80µL of ddH 2 O was added. This was mixed and 5µL of the solution
was taken and added to 10µL of redry solution. The same thing was done for the methionine
sulfoxide standard except 16.5 mg was taken and diluted. For the 5:1 standard, the same amount
of the amino acid standard H was used and only 1µL of a 25nmol solution of methionine
sulfoxide was used. The same amount of redry solution was added to all of the standards.3
The rat liver procedure was exactly the same as the urine except for the first few steps.
The rat liver was allowed to thaw and then weighed out to be approximately 200 mg. Then the
liver was cut into smaller pieces with a sterile razor blade and put into the hydrolysis tube. Here
the MSA was added and the procedure starts at the freeze-pump-thaw step.

Results and Discussion
The following are the chromatograms from the analysis of the standards. With these
chromatograms, we were able to see in which range the peaks of our interest were. The
methionine comes out at approximately 17.5 on most of the chromatograms (graph1). The
methionine sulfoxide normally came out at 11.2, (graph 2) but you can see that there are quite a
few other peaks in that area (graph 3). To make sure we were using the correct peak, we spiked
an amino acid standard with a methionine sulfoxide (graph 4) and analyzed it. This let us know
for sure which peak we were looking at.
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The next set of chromatograms is from the urine samples of smokers and nonsmokers.
The peaks that are marked are the methionine sulfoxide at 11.2 minutes and the methionine at
17.5 minutes. These graphs do not show very much until the ratios of the areas are measured.
63

Graph 9 shows 2 chromatograms lined up against one another. As you can see, the methionine
sulfoxide peak is bigger for the smoker than the nonsmoker.
TMU-3 (nonsmoker) (graph 5)
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TMU-110 (smoker) (graph 7)
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TMU-114 (smoker) (graph 8)
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TMU-7 and TMU-100 (the smoker is the darker gray) (graph 9)
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The next chromatogram is of the rat liver samples. It has been normalized so the
comparison of the peaks is easier to visualize. The control sample is just a normal rat. The other
2 samples were injected with an overdose of acetaminophen. The rats were killed either 2 hours
or 4 hours after the injection. Graph 10 clearly shows that the methionine sulfoxide peak is
largest for the 4 hour sample and it decreases with the 2 hour and again with the control. The
next graph (11) shows that the methionine peak does not correlate with the increase of
methionine sulfoxide.
(graph 10)
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(graph 11)
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Conclusion
The results from the urine studies show that there is an increase in the levels of
methionine sulfoxide in smokers. The methionine level does decrease as the methionine
sulfoxide level increases. On average, the ratio of methionine sulfoxide to methionine is higher
for smokers than nonsmokers. For the rat livers, when the acetaminophen is injected, the
oxidation of methionine follows the same trend as in the urine. The acetaminophen makes it
increase over time. However, the levels of methionine do not decrease as methionine sulfoxide is
increased. There will be future tests with mass spectroscopy to see if there is indeed something
more to the methionine sulfoxide peak than what we think.
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Development of Polyeugenol Coated Electrodes for Chemical Sensors
Michelle Reed, Adams State College
Alamosa, Colorado

Abstract
Oxygen sensing in AA/ACSF represents the most demanding case for oxygen sensing and is
most similar to in-vivo use. The electrochemical technique of cyclic voltammetry (CV) was
used to electropolymerize a eugenol Filmover A gold electrode and to detect oxygen in KCl
or AA/ACSF. In this work, eugenol-coated gold electrodes were uniformly coated, tested
for degradation, compared against Nafion® for linearity over a large concentration range
of oxygen, and used to sense oxygen from potassium chloride (KCl), artificial cerebrospinal
fluid (ACSF), and ascorbic acid in artificial cerebrospinal fluid (AA/ACSF). It can be
concluded that eugenol successfully protects the gold from fouling in AA with ACSF, while
remaining permeable and sensitive to oxygen.

Introduction
There are many incentives to develop in-vivo oxygen sensors, including the ability to
directly measure oxygen levels in brain tissue. The brain depends on the constant, uninterrupted
delivery of oxygen to prevent secondary injury. Oxygen levels are known to vary in the brain
and other tissues as a result of injury or stroke. According to Littlejohns, et al., monitoring the
partial pressure of brain tissue oxygen may help prevent hypoxia events and improve patients’
outcomes.1
Currently, there are several methods of measuring oxygen levels in the brain in-vivo,
Nuclear Magnetic Resonance (NMR), fluorescence quenching, or Electron Spin
Resonance/Magnetic Resonance Imaging (ESR/MR); however, each of these methods has its
own limitations, most notably with regard to the ability to make repeated measurements with
minimum invasiveness and high sensitivity.2 Electrochemical detection presents one of the most
promising ways of measuring brain tissue oxygen levels at different locations in the brain.
One major problem with in-vivo oxygen sensing electrochemically is that bare electrodes
foul on coming into contact with bio-components. To prevent fouling, a protective coating is
applied directly to the electrode surface.3 Traditionally, Nafion® has been the standard electrode
coating, acting as an anionic molecular filter and limiting the access of large molecules to the
electrode surface. Nafion® is applied by a “dipping method,” which coats not only the electrode,
but all of the inert structural materials surrounding the electrode.
This paper reports on the performance of an alternative coating, electropolymerized
eugenol, as a sufficient protective film for oxygen sensing. The objective of this research was to
determine whether eugenol-coated electrodes could be consistently and uniformly coated to
become impermeable to large molecules, while still remaining permeable to oxygen.
In this work, eugenol-coated gold electrodes were uniformly coated, tested for
degradation, compared against Nafion® for linearity over a large concentration range of oxygen,
and used to sense oxygen from potassium chloride (KCl), artificial cerebrospinal fluid (ACSF),
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and ascorbic acid in artificial cerebrospinal fluid (AA/ACSF). Oxygen sensing in AA/ACSF
represents the most demanding case for oxygen sensing and is most similar to in-vivo use. The
electrochemical technique of cyclic voltammetry (CV) was used to electropolymerize the
eugenol and to detect oxygen in KCl or AA/ACSF. Chronoamperometry (CA) was used to
detect dissolved oxygen with both Nafion® and eugenol coatings and compare their performance
over a large concentration range.

Experimental Procedures
Electrodes:
The solution used for the dissolved oxygen experiments was a 0.1 M KCl (Fisher
Scientific, Pittsburgh, PA) made with reagent grade deionized water (Ricca Chemical Company,
Arlington, TX). The dissolved oxygen concentration was lowered by bubbling nitrogen gas
(AirGas, Springdale, AR) through the solution. The dissolved oxygen concentration was
measured by using a YSI (Yellow Springs Instruments, Ohio) model 55 Dissolved Oxygen
Meter. Two mm gold disk (CHI Instruments, Austin, TX) electrodes were used as working
electrodes. The gold disk electrodes were polished using 1.0 µm diamond polish, rinsing with
deionized water followed by methanol (EMD Chemicals, Gibbstown, NJ), polishing again with
0.05 alumina, rinsing again with both water and methanol.5 The electrode was then further
cleaned in heated RCA-1 solution for 15 min. to remove any residual organic material before use
in any cyclic voltammetry (CV) or chronoamperometry (CA) experiments. RCA-1 solution is
made of 4 mL 27% NH 4 OH (VWR International, West Chester, PA), 4 mL 30% H 2 O 2 (VWR
International, West Chester, PA), and 20 mL deionized water heated to 75°C.6 The reference
electrode was a saturated calomel electrode (SCE) and the auxiliary was a platinum flag. All
chronoamperograms and cyclicvoltammagrams were obtained on a CHI 830 potentiostat.
Calibration Curves:
Both the YSI DO meter and the electrodes were placed in the test solution. Operation of
the YSI DO meter requires the solution to be stirred for accurate measurement. However, any
CV experiment requires a static solution. To construct a calibration curve for the working
electrode, the test solution was first stirred (Fisher Thermix Stirrer Model 120M) at a speed of 4,
while nitrogen bubbled through the solution. The gas flow was stopped around a DO reading of
0.10 mg/L and any bubbles clinging to the working electrode and DO meter are knocked-off.
Stirring continued until the first DO meter reading was taken at around 0.15 mg/L. The magnetic
stir was turned off, and CV or CA collected after waiting approximately five seconds for the
solution to settle. CVs were performed from +0.5 V to -1.0 V at 0.1 V/s. CAs were taken from
0.0 V to -1.0 V with a 15 sec. pulse width. At the conclusion of the CV or CA experiment, the
magnetic stirrer is turned back on and the DO concentration allowed too rise to the next level.
This process continued until the DO level reached close to 6.50 mg/, oxygen saturation in
ambient air. A calibration curve was then constructed from the CV data points at -0.60 V or the
CA data points at 14 sec.
Film Formation:
Nafion® membranes were cast on the working electrodes by pipetting 5 wt% Nafion® in
alcohol solution (Aldrich, St. Louis, MO) onto the electrode surface and air drying for at least
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one hour. Films were formed such that different thicknesses could be achieved. Film
thicknesses was calculated (based on density) using a program on Excel spreadsheet provided by
Dr. Johna Leddy’s group.7 For the purpose of these experiments only one thickness of 6 µm was
used.
Electropolymerization:8
Eugenol was electropolymerized onto gold electrodes by sweeping the potential from
+0.7 V to 0.0 V at 0.1 V/s for 40 sweep segments. The electropolymerizing solution was a 10
mM eugenol (Alfa Aesar, Ward Hill, MA) made with 0.1 M sodium hydroxide (Fisher Scientific,
Pittsburgh, PA). The films exclusion of large molecules was tested using
hexaammineruthenium(III) chloride (RuHex, 10 mM, Alfa Aesar, Ward Hill, MA) made with
0.1 M KCl . Complete loss of the RuHex (III) signal was taken to mean that eugenol film was
complete. CVs in the RuHex were performed from +0.2 V to -0.5 V at a scan rate of 0.02 V/s.
RuHex(III) exclusion was also used to test for degradation of the eugenol coating over time.
Dissolved Oxygen Permeability:
The solution used to test in-vitro dissolved oxygen permeability of the polyeugenol
coating was 0.5 mM L-ascorbic acid (Alfa Aesar, Germany) in ACSF. ACSF is a binary mixture
and was made according to the recipe outlined by Ferriera, et al.4 The first solution contained
117 mM NaCl, 4.69 mM KCl, 1.20 mM MgSO 4 ·7H 2 O, 1.18 mM NaH 2 PO 4 , and 2.49 mM
CaCl 2 . The second solution contained 11.5 mM D-glucose and 24.9 mM NaHCO 3 . The
separate solutions were combined to yield the components in the present concentrations just
before testing. All methods and parameters used for DO experiments in 0.1 M KCl solution were
kept the same.

Results and Discussion
Dissolved Oxygen:
The dissolved oxygen experiments were performed to practice experimental techniques,
provide a reference, and to establish calibration curves. Learning to collect CAs, CVs and using
those to create accurate calibration curves was essential for data analysis. It should be noted that
the appearance of the oxygen CAs and CVs was never consistent from day to day. Even when
using the same electrode and test solution there were always some differences noted. This is
most likely due to changes of the electrode over time. However, constructing calibration curves
from peak currents at -0.6 V from CVs and any pulse step from CAs always provided linear
calibration.5
Advantages of Electropolymerized Films:
The technique of chronoamperometry (CA) was chosen to compare the calibrations
curves for oxygen obtained by of the polyeugenol coating to that of Nafion.® Figure 1 shows the
dissolved oxygen curves from varying concentrations using (CA). In this technique, the
potential of an electrode is instantaneously adjusted from a value with no net current, to a new
value with a net current. The magnitude of the resulting current decays continuously with time,
but at any given moment is directly proportional to the concentration of the reactant in solution.9
This is mathematically modeled by the Cottrell equation:10
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where (I) is the current in amperes, (n) is the of moles of electrons per mole reactant, (F) is the
Faraday (coulombs per mole of electron), (A) is the electrode area in sq cm, (t) is the time in
seconds since the application of the potential pulse, (D) is the diffusion coefficient of the reactant
in sq cm per sec, and (C) is the initial concentration of reactant in moles per cubic cm.
Figure 2 shows that dissolved oxygen calibration curves resulting from the measured
current of the CA at 14 seconds after application of -1.0 V step and indicates that the calibration
curve using Nafion® is non-linear, while eugenol is linear. Nafion® has long been the polymer of
choice for coating electrodes. It is easy to apply by a “dipping method,” but this method also
coats the entire electrode/insulator assembly instead of only the gold electrode surface as seen in
figure 3. This can be a problem because the coating on the insulator surrounding the electrode
creates a “trapped” oxygen effect. The signal from “trapped” oxygen was found to be more
pronounced using chronoamperometry (CA) than cyclic voltammetry. The higher DO
concentrations and shorter times cause the “bleed-in” of the “trapped” oxygen in the Nafion®
coating to be worse due to the high concentration gradient within the coating.
Overall it is apparent that eugenol is a better polymer for coating electrodes because it
electropolymerizes only on the gold surface, eliminating the “trapped” oxygen effect seen in the
Nafion® coating.

Figure 1. Overlay of CAs for Eugenol coated 2.0 mm Au electrode in KCl
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Figure 2. Dissolved Oxygen Calibration Curves for a 2.0 mm Au electrode coated with
Nafion and Eugenol
O2 Endogenous
O2

O2

Endogenous

Trapped

O2

Gold Surface

Nafion® Coating

Electrode insulator

Polyeugenol Coating

Figure 3. Nafion® and polyeugenol coatings on 2 mm Au electrodes

Good and Bad Eugenol Electropolymerization Coatings:
Figures 4 and 5 are the electropolymerization of eugenol onto the gold electrode surface.
The electrode used in figure 4 was only mechanically polished before electropolymerization.
The same electrode was cleaned in RCA-1 solution, and then electropolymerized to yield figure
5. The RCA-1 cleaning makes a very large difference in the data collected during
electropolymerization and the performance of the resulting eugenol coating. Permeability of the
coating to large molecules was tested using RuHex(III). Ideally, the coating should completely
block RuHex(III). Figure 6 shows the overlay of a CV of RuHex(III) with a bare electrode, the
poor eugenol-coated electrode (from Figure 4), and the good eugenol-coated electrode (from
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Figure 5). The sharp increase in current on the bare electrode scan indicates the reduction of
RuHex(III) to RuHex(II) and shows that the RuHex(III) has full access to the bare electrode.
The CV of the poor eugenol-coated working electrode still has some of the RuHex(III)
oxidation/reduction signals present, indicating that the RuHex(III) has not been completely
blocked from the electrode surface due to an insufficient eugenol coating. It can be seen that the
insufficiently eugenol-coated electrode shows a RuHex reduction peak at -0.20 V. However, the
CV with the good eugenol-coated working electrode lacks the RuHex(III) oxidation/reduction
signals, indicating that the RuHex(III) has been blocked from the electrode surface. This
confirms that the good eugenol coating was obtained by thoroughly polishing the electrode and
then cleaning in the RCA-1 cleaning solution.
Overall, it is possible to determine whether or not complete coatings are being produced
just by examining the results of the electropolymerization CVs. In addition, Figure 6 clearly
shows that a good electropolymerization of a eugenol coating prevents large molecules, such as
RuHex(III), from reaching the electrode. A good eugenol coating was always obtained by
polishing the electrode and then cleaning with the RCA-1 cleaning solution. Failure to clean
with RCA-1 consistently resulted in a poor coating.

Figure 4. Poor eugenol electropolymerization on a 2.0 mm Au electrode

73

Figure 5. Good eugenol electropolymerization on a 2.0 mm Au electrode

Figure 6. Effect of good and bad eugenol coatings on a 2.0 mm Au electrode in RuHex(III).
Degradation Studies:
Once formed over the electrode, a limited attempt was made to determine the stability
and shelf –life of the eugenol films. Films were tested by determining permeability to RuHex
(III). The first day, the eugenol-coated electrode was simply stored in DI water and tested for
impermeability to RuHex. On day two, the same electrode was used to make DO calibration
curves in ACSF and then stored in DI water for another 24 hours. On day three, the same
electrode was again used to repeat the DO calibration curves in ACSF. Figure 7 shows that the
eugenol-coated electrode actually becomes more sensitive to oxygen after exposure to ACSF.
The CV taken after day one shows no RuHex peak present, which implies no eugenol
degradation will occur after one day of storage in DI water. The CV taken after day two shows
that even after the eugenol-coated electrode was used in ACSF to construct a calibration curve, it
is still impermeable to RuHex, while becoming more sensitive to oxygen. The CV taken before
day three still shows no RuHex peak present, but it has become less sensitive to oxygen after
storage in DI water. The CV taken after day three still shows no RuHex peak present, but it has
become even more sensitive to oxygen after a second use in ACSF. No degradation of the
polyeugenol film was evident even after three days of experiments.
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D
B
C
A

(A) After Day 1 - only DI water storage
(B) After Day 2 – First use in ACSF, stored in DI water afterwards
(C) Before Day 3 – After storage in DI water from Day 2
(D) After Day 3 – Second use in ACSF
Figure 7. Overlay of CVs for Eugenol coated 2.0 mm Au electrode in RuHex before and
after use in ACSF
Performance of Eugenol coated Au electrode in AA with ACSF:
Figure 8 is the overlay of CVs recorded to determine the oxygen sensitivity of the bare
2.0 mm Au electrode in ACSF.3 The data show no relationship between peak current and
dissolved oxygen concentration. Repeated experiments yielded similar results. It can be
concluded that a bare gold electrode cannot be used to sense oxygen in-vitro due to fouling. By
some mechanism, the gold electrode becomes insensitive to oxygen, most likely, due to the
reduction of glucose obstructing the electrode surface.
Conversely, figure 9 is the same experiment as in figure 8, but with a eugenol coated
electrode. This illustrates that the eugenol coating is able to protect the gold electrode from
fouling while still remaining permeable and sensitive to oxygen. While detecting dissolved
oxygen in the AA/ACSF mixture, it was observed that the dissolved oxygen meter was unable to
detect more than 4.48 mg/L. This is a much lower reading than normally obtained, even when
only ASCF is used as seen in figure 10. In many recent studies, it has been found that the rate of
consumption of dissolved oxygen is directly dependent on the concentration of AA.11,12 The
homogeneous reaction between oxygen and AA limits the oxygen concentration to less than 4.5
mg/L.
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Figure 8: Overlay of CV’s for Bare 2.0 mm Au electrode in ACSF 3

Figure 9. Overlay of CVs for Eugenol coated 2.0 mm Au electrode in 0.5 mM Ascorbic
Acid in ACSF

76

0.000006

y = 7E-07x + 1E-06
R2 = 0.9957

Current (A)

0.000005
0.000004

ACSF

0.000003
0.000002

AA

y = 7E-07x + 9E-07
R2 = 0.997

0.000001
0
0

2

4

6

8

DO (mg/L)

Figure 10. Dissolved Oxygen Calibration Curves for a Eugenol coated 2.0 mm Au
electrode in ACSF and in 0.5 mM Ascorbic Acid in ACSF

Conclusions
This research was successful in showing the benefits of using a polyeugenol coating for
in-vivo oxygen sensing. Eugenol only electropolymerizes onto the Au electrode surface,
eliminating the “trapped” oxygen effect observed in the Nafion® coating. Eugenol also displays
no signs of degradation after repeated use in ACSF, it actually seems to become more sensitive
to oxygen detection. RCA-1 cleaning will also result in a uniform coating that is still sensitive to
oxygen and impermeable to large molecules like RuHex. The eugenol coating is also sufficient
for use in ascorbic acid in ACSF because it will not foul like a bare Au electrode will. Overall it
appears that a polyeugenol coated electrode is a promising option for in-vivo chemical sensors.
Future work could include repeating the degradation experiments with a Nafion® coated Au
electrode to see if it also becomes more sensitive to oxygen after exposure to ACSF.
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Analysis of Plasma Polymerized Acetylene Films on Silicon Chips by Fourier
Transform Mass Spectrometry
Scott Robotham, Nebraska Wesleyan University
Lincoln, Nebraska

Abstract
Positive and negative ion mode laser desorption/ionization-Fourier transform mass
spectrometry was used to analyze the films formed by plasma polymerization of acetylene
on silicon chips. From the three films discussed here, it can be seen that a bipolar discharge
method of plasma polymerization results in a much larger relative number of hydrocarbon
oligomers in the film compared to unipolar discharge and continuous discharge methods.
All films showed carbon cluster formation. It was also discovered that in the increasing of
the thickness of the film leads to a broader mass range spectrum.

Introduction
Since its invention in 1974,1 Fourier transform mass spectrometry (FTMS) has become
known as one of the most powerful forms of instrumentation in the field of analytical chemistry.2
FTMS offers superior resolving power and mass accuracy; the reason is the use of the ion
cyclotron resonance (ICR) cell as mass analyzer. The ICR cell is usually a box or a cyclinder
using three pairs of electrodes. The pair perpendicular to magnetic field is used to trap the ions.
Once inside the cell, ions are excited to stable cyclotron orbits by a short on resonance radio
frequency (rf) pulse, produced by two opposing ICR cell electrodes positioned parallel to
magnetic field. The ion motion in cyclotron orbit is defined by ion cyclotron frequency which
depends on m/z of the ion and the magnetic field strength. This frequency is detected by the two
remaining electrodes and displayed as a time domain spectrum. The time domain spectrum can
be Fourier transformed to yield a frequency spectrum that can be displayed as an m/z spectrum.3
The unmatched mass accuracy and resolving power makes it possible to determine the difference
between isobars. Isobars are signals of ions that have the same nominal mass but differ in
fractional mass. The ability of FTMS to distinguish this difference makes it possible to analyze
and identify compounds and mixtures that were impossible to study before.
Molecules have to be in charged or ionized form in order to be analyzed. One of the most
widely used ionization methods is to use a laser to create the ions from the sample - a method
called laser desorption/ionization (LDI), and it was commonly done using a pulsed CO 2 IR
laser.4,5 LDI is very effective for ionizing, and vaporizing smaller particles, however when
molecules are too large it becomes ineffective at creating molecular ions. This problem was
solved by the discovery of matrix assisted laser desorption/ionization (MALDI). MALDI uses an
ultraviolet laser, rather than a CO 2 laser for desorption. In MALDI, the sample is premixed with
an excess of an ultraviolet (UV) light adsorbing molecule, the matrix. The matrix efficiently
absorbs and transfers the UV laser light and thus the ionization energy to the analyte.6-8 Using
this method it is possible to ionize particles as large as 1.5 million Daltons.9
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Desorption/ionization on porous silicon (DIOS) is a novel LDI method that uses silicon
to enhance the analyte ionization. It has been found that silicon behaves as a UV matrix,
producing softer ionization and increasing the signal to noise ratio of mass spectrum relative to
more common MALDI matrices.10,11
Plasma polymerization is one of the newest techniques in polymer synthesis. It can be
used to form a thin film polymer layer that can range from 10 nm to 1 µm in thickness. Such
films have many different uses such as protective coatings, electronics, permselective
membranes, and biomedical materials.12,13 The plasma polymerization of acetylene on silicon
chips has recently been a process that has attracted the interest of many researchers around the
world. There have been several papers that have discussed in detail the type of reactants found in
the plasma by IR absorption and mass spectrometry analysis.14 However, to our knowledge, there
has never been analytical analysis of the film formed on the silicon wafer.
In the following research, Fourier transform mass spectrometry has been used to identify
the products formed by plasma polymerization of acetylene on silicon chips. Three chips are
analyzed in this report. Each chip was formed using a different discharge method, one with
unipolar, one with bipolar, and the last one with continuous discharge. Both positive and
negative DOIS-FTMS spectra were collected. The analysis indicates a difference in the acetylene
products of constituting each film.

Experimental Methods
LDI-FTMS was done on an IonSpec/Varian (Lake Forest, CA) with a 9.4 Tesla
superconducting magnet, and an external ionization source. The system is equipped with a 355
nm Nd-YAG laser. The ions were guided into the ion cyclotron resonance cell using RF
quadrupole ion optics. The spectra were acquired in both positive and negative ion modes at a
pressure of ~3x10-10 Torr. Each spectrum was a result of 6 laser pulses. For each laser pulse the
quadrupole settings were adjusted in order to guide a different mass range in the sample. This
allowed us to achieve a final spectrum that had a broad mass range from 300 to 5000 m/z.15
Each sample was given a code which was assigned by listing the date which it was made,
and also a letter to indicate which came first in that day. The samples analyzed in this report
were the following: for the unipolar discharge 080225A; for the bipolar discharge 071128F; and
for the continuous discharge 080602B.

Results and Discussion
Each film was analyzed in both the positive and negative ion mode as mentioned above.
Also for each spectrum the M n , M w , and the polydispersity (PD) was calculated using the
following equations:
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where M is mass of peak of i and R is the relative abundance of peak i.16
The unipolar discharge film (080225A) showed only carbon clusters, with m/z ranging
from 720 to 2040 in the positive ion mode (Fig. 1A). The average resolving power was ~42,000,
with M n = 1438, M w = 1504, and PD= 1.05 found using Eq. 1-3. In the negative ion mode, the
spectrum had peaks with an m/z range of 552 to 1954, and showed both hydrocarbon oligomers
and carbon clusters (Fig. 1B). The average resolving power was ~37,000 and M n = 1361, M w =
1421, and PD= 1.04.
The bipolar discharge (071128F) film had an m/z range from 505 to1873, and showed
both hydrocarbon oligomers and carbon clusters (Fig. 2A). The average resolving power was
~8,000, with M n = 1119, M w = 1211, and PD= 1.08. The negative ion spectrum had hydrocarbon
oligomers and carbon clusters with an m/z range of 779 to1969 (Fig. 2B). This spectrum had an
average resolving power of ~23,000 and M n = 1354, M w = 1407, and PD= 1.04.
For the continuous discharge film (080602B) the positive ion spectrum showed a small
amount of hydrocarbon oligomers and carbon clusters, however there are two different m/z
distributions in the spectrum that span an m/z range of 720 to 4584 (Fig. 3A). The average
resolving power of the spectrum was ~18,000. For this spectrum two separate sets of M n , M w ,
and PD values were taken. For the first distribution the values are M n = 1543, M w = 1660, and
PD= 1.08, and for the second distribution M n = 3757, M w = 3813, and PD= 1.01. The negative
ion mode spectrum also had very wide distribution of carbon clusters with a m/z range from 520
to 4320. There were also a few hydrocarbon oligomers in the lower mass ranges (Fig. 3B). For
the negative mode the average resolving power was ~27,000 with once again two sets of M n ,
M w , and PD values. The first set was M n = 1313, M w = 1530, and PD= 1.16, and the second set
of values was M n = 3745, M w = 3780, and PD= 1.01.
In the positive ion mode, spectra carbon clusters are clearly the most abundant
component of the sample. These clusters are very stable, and also differ from one another by two
carbons. In all positive spectra C 60 and C 70 are found in relatively high abundance because of
their stability as positive ions. It has been reported that in LDI of hydrocarbon samples tend to
form carbon clusters.17 However, we believe that carbon clusters are not formed by LDI in film
samples because a number of film samples did not produce carbon cluster signals in FTMS
spectra (data not shown). In order to completely determine if carbon clusters are formed on the
silicon chips X-ray photoelectron spectroscopy should be performed.
The negative ion mode spectra also show carbon clusters as more abundant, however
there is a much greater number of hydrocarbons present. In these spectra, the unmatched
resolving power of FTMS is necessary in assigning of the isobars (Fig 4). These hydrocarbons
have a much higher number of carbons then hydrogens in the structures, and the oligomers show
a pattern of having either an even number of carbons and hydrogens, or an odd number of both
carbons and hydrogens. There are no signals found in any sample that have even number of
carbons and an odd number of hydrogens, or an odd number of carbons and an even number of
hydrogens. The reason that this pattern is present in the oligomers is still unclear; further
research is needed in order to determine the answer to this problem.
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The bipolar discharge film (071128F) showed a much higher abundance of hydrocarbon
oligomers then any of the other films (Fig. 5C and D). These oligomers were even found in fairly
high abundance in the positive ion mode spectrum. The results indicate that bipolar discharge
leads to a much greater formation of hydrocarbon oligomers in the plasma polymerization.
The continuous discharge film (080602B) shows a much broader mass range then the
other two films because the thickness of this film is approximately 3x thicker then the all of the
other films. The continuous discharge film also shows a small number of hydrocarbon signals
compared to that of the bipolar discharge method (Fig. 5B), indicating that the continuous
discharge during plasma polymerization results in a much greater formation of carbon clusters.
The unipolar discharge film (080225A) negative ion mode spectra also shows far less
hydrocarbon formation compared to that of the bipolar discharge film, but is similar to the
continuous discharge film (Fig. 5A). The difference between the continuous discharge and the
unipolar discharge negative ion spectra is that the continuous discharge spectrum has a much
broader mass range for the carbon clusters, and also hydrocarbons are spread out over two
distributions whereas in the unipolar spectrum there is only one distribution.

Conclusion
A strategy for performing positive and negative ion mode LDI-FTMS analysis of plasma
polymerized acetylene on silicon chips has been described. The results of this analysis show the
presence of carbon clusters and hydrocarbon oligomers in different amounts. It is clear from the
spectra that bipolar method of plasma polymerization forms a greater amount of hydrocarbon
oligomers compared to that of unipolar and continuous discharge. It can also be seen that if the
thickness of the film is increased this leads to a broader mass range in the spectrum.
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Appendix

A

B

Figure 1.LDI-FTMS spectra of Unipolar Discharge Film: a) positive ion mode, b) negative ion
mode. Insets are showing partial spectrum with assignments of the most abundant peaks with
calculated molecular weights and average resolving power
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A

B

Figure 2. LDI-FTMS spectra of Bipolar Discharge Film: a) positive ion mode, b) negative ion
mode. Insets are showing partial spectrum with assignments of the most abundant peaks with
calculated molecular weights and average resolving power
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A

B

Figure 3. LDI-FTMS spectra of Continuous Discharge Film: a) positive ion mode, b) negative
ion mode. Insets are showing partial spectrum with assignments of the most abundant peaks with
calculated molecular weights and average resolving power
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C108
(13C) C107
C106 H24
(13C) C105

Figure 4. Inset of LDI-FTMS spectrum of Bipolar Discharge Film with assignments of four
isobars (average error = 1.7 ppm)
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A

C

B

D

Figure 5. Plots of number of hydrogen versus number of carbons in hydrocarbon oligomers.
Spectra that produced only carbon clusters are not plotted.
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Racemization of Chiral Lithium Carbanions: An Exercise in Organic
Synthesis, Analytical Chemistry, Solution Kinetics, and Chemical
Thermodynamics
Andrew Ward, University of Detroit Mercy
Detroit, MI

Abstract
Chiral lithium carbanions are key intermediates in the synthesis of natural products and
pharmaceuticals since they are easily generated using a chiral base and they can retain
their structural integrity. The objective of this research is to study the rate of racemization
for these chiral carbanion molecules both in the presence and absence of diamine ligands.
The molecules were synthesized and then analyzed with GC-MS, and 13C NMR and 1H
NMR. The molecules were purified for experiments using CSP-SFC analysis.

Introduction
The study of chirality in various organic molecules is of the utmost importance to the
pharmaceutical industry and the world at large. The proteins and carbohydrates in all living
organisms are chiral. Naturally occurring proteins are all derived from S-amino acids while
carbohydrates are all derived from R-sugars. It is thusly evident why the synthesis and research
of chiral molecules is a large focus for the pharmaceutical industry. In many cases, only one of
the enantiomers of a chiral molecule is pharmacologically active. The other enantiomer could be
pharmacologically inactive and, in the worst cases, highly toxic to the receiver of the drug. One
such case of the industry marketing the wrong enantiomer as the active drug involved the drug
thalidomide. The racemate acted as a sedative for women with morning sickness whereas the Renantiomer alone acted as a teratogen. Since the molecule racemizes in vivo, the R-enantiomer
of thalidomide caused the women who took it to give birth to seriously deformed children.
O
O

N
O

O

N
H

Fig. 1. Racemic structure of thalidomide.
Chiral lithium carbanions are imperative to pharmaceutical companies for the synthesis
of natural products.1,2 These intermediates can be easily generated using chiral bases and retain
their structural integrity at low temperatures.3-5 Quenching the carbanion with an electrophile
allows for the generation of a new chiral center at the point of lithiation.6-8 In this project, the
interest is in the rate at which the chiral carbanions racemize both in the presence and absence of
diamine ligands. The carbanion studied is 2-Li-N-Boc-piperidine (2) which is generated by
Sn/Li exchange from the corresponding stannane (1) as show in Figure 2. The generation of
piperidine-based stannanes and silanes, as well as diamine ligands, is vital to the next steps of the
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research project, namely the kinetics and thermodynamics resolution studies.
ligand

n-BuLi
N
Boc

(1)

SnBu3

ether

N

N

Li

+ SnBu4

Boc

Li*ligand

Boc

+

N

Li*ligand

Boc

(2)

(3)

(4)

Fig. 2. Sn/Li exchange with complexation of ligand to the racemic lithiated carbon atom.
The corresponding studies with the analogous N-Boc-pyrolidine and N-trimethylallyl-pyrolidine
systems have already been completed.9,10

Experimental Details
1. Synthesis of N-Boc-Piperidine
(Boc)2O (0.12 mol)
N
H

CHCl 3

N
Boc

(5)

(6)

To a 250 mL round bottom flask, 100 mL of CHCl 3 and 26.2 g (0.12 mol) of t-Butoxycarbonate
were added. 9.88 mL (0.1 mol) of piperidine (5) were added to the round bottom flask that was
attached to the addition funnel. The solution was then added dropwise over three hours while
stirring. Afterwards, the organics were washed with water three times and dried over magnesium
sulfate. Then, the CHCl 3 solvent was removed on the rotary evaporator to afford product (20.4
g; 0.12 mol; 100% yield). The product (6) was vacuum dried in the hood prior to use in order to
remove excess solvent and stored with a piece of CaH 2 .
2. Synthesis of N-Boc-piperidne
(Boc)2O (0.1 mol)
N
H

(5)

CHCl 3

N
Boc

(6)

To a 250 mL round bottom flask, 100 mL of CHCl 3 and 21.8 g (0.1 mol) of t-Butoxycarbonate
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were added. 9.88 mL (0.1 mol) of piperidine (5) were added to the round bottom flask that was
attached to the addition funnel. The solution was then added dropwise over three hours while
stirring. Afterwards, the organics were washed with water three times and dried over magnesium
sulfate. Then, the CHCl 3 solvent was removed on the rotary evaporator to afford product (18.5
g; 0.1 mol; 100% yield). The product (6) was vacuum dried in the hood prior to use in order to
remove excess solvent and stored with a piece of CaH 2 .
3. Synthesis of 2-(trimethylsilyl)-N-Boc-piperidine
secBuLi (0.03 mol)
TMEDA (0.03 mol)
50 mL ether

N

0

N

0

-80 C
3 hrs

Boc

Bu3SnCl (0.03 mol)
Li -80 C -> rt, overnight

SiMe3

Boc

Boc

(6)

N

(2)

(7)

A 250 mL round bottom flask was dried in the oven and then cooled in the desiccator to remove
all moisture. A septum was put on top of the cooled flask. Through the septum, 50 mL ether,
1.9 mL (0.01 mol) of N-Boc-piperidine (6), and 4.5 mL (0.03 mol) of TMEDA were added by
syringe. The reaction flask was cooled to -80 0C under argon pressure. 21 mL (0.03 mol) of secBuLi was added slowly to the side of the flask. The reaction was left stirring at this temperature
for three hours. 3.8 mL (0.03 mol) of Me 3 SiCl was slowly added to the reaction, which was then
allowed to come to room temperature overnight. Afterwards, 100 mL of deionized water was
added to the reaction to dissolve the precipitate of LiCl. The organics were washed with 100 mL
of ether, dried over magnesium sulfate, and the solvent was removed on the rotary evaporator.
The product (7) was purified by column chromatography with 98% hexanes: 2% ethyl acetate as
the mobile phase.
4. Synthesis of 2-(trimethylstannyl)-N-Boc-piperidine
secBuLi (0.03 mol)
TMEDA (0.03 mol)
N
Boc

(6)

50 mL ether
0

-80 C
3 hrs

Bu3SnCl (0.03 mol)
N
Boc

(2)

0

Li -80 C -> rt, overnight

N

SnBu3

Boc

(1)

A 250 mL round bottom flask was dried in the oven and then cooled in the desiccator to remove
all moisture. A septum was put on top of the cooled flask. Through the septum, 50 mL ether,
1.9 mL (0.01 mol) of N-Boc-piperidine (6), and 4.5 mL (0.03 mol) of TMEDA were added by
syringe. The reaction flask was cooled to -80 0C under argon pressure. 21 mL (0.03 mol) of secBuLi was added slowly to the side of the flask. The reaction was left stirring at this temperature
for three hours. 8.1 mL (0.03 mol) of Bu 3 SnCl was slowly added to the reaction, which was then
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allowed to come to room temperature overnight. Afterwards, 50 mL of 2M HCl was added to
the reaction to dissolve the precipitate of LiCl. The organics were washed with 100 mL of ether,
dried over magnesium sulfate, and the solvent was removed on the rotary evaporator. The
product (1) was purified by column chromatography with hexanes as the mobile solvent.
5. Synthesis of 2-(trimethylstannyl)-N-Boc-piperidine
secBuLi (0.03 mol)
TMEDA (0.03 mol)
N
Boc

50 mL ether
0

-80 C
3 hrs

Bu3SnCl (0.03 mol)
0

N

Li -80 C -> rt, overnight

SnBu3

Boc

Boc

(6)

N

(2)

(1)

A 250 mL round bottom flask was dried in the oven and then cooled in the desiccator to remove
all moisture. A septum was put on top of the cooled flask. Through the septum, 50 mL ether,
1.9 mL (0.01 mol) of N-Boc-piperidine (6), and 4.5 mL (0.03 mol) of TMEDA were added by
syringe. The reaction flask was cooled to -80 0C under argon pressure. 21 mL (0.03 mol) of secBuLi was added slowly to the side of the flask. The reaction was left stirring at this temperature
for three hours. 8.1 mL (0.03 mol) of Bu 3 SnCl was slowly added to the reaction, which was then
allowed to come to room temperature overnight. Afterwards, 50 mL of 2M HCl was added to
the reaction to dissolve the precipitate of LiCl. The organics were washed with 100 mL of ether,
dried over magnesium sulfate, and the solvent was removed on the rotary evaporator. The
product (1) was purified by column chromatography with hexanes as the mobile solvent.
6. Synthesis of N-Boc-piperidine
(Boc)2O (0.1 mol)
N
H

(5)

CHCl 3

N
Boc

(6)

To a 250 mL round bottom flask, 100 mL of CHCl 3 and 21.8 g (0.1 mol) of t-Butoxycarbonate
were added. 9.88 mL (0.1 mol) of piperidine (5) were added to the round bottom flask that was
attached to the addition funnel. The solution was then added dropwise over three hours while
stirring. Afterwards, the organics were washed with water three times and dried over magnesium
sulfate. Then, the CHCl 3 solvent was removed on the rotary evaporator to afford product (18.5
g; 0.1 mol; 100% yield). The product (6) was vacuum dried in the hood prior to use in order to
remove excess solvent and stored with a piece of CaH 2 .
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7. Synthesis of N-Boc-piperidine
(Boc)2O (0.1 mol)
N

CHCl 3

N
H

Boc

(5)

(6)

To a 250 mL round bottom flask, 100 mL of CHCl 3 and 21.8 g (0.1 mol) of t-Butoxycarbonate
were added. 14.8 mL (0.15 mol) of piperidine (5) were added to the round bottom flask that was
attached to the addition funnel. The solution was then added dropwise over three hours while
stirring. Afterwards, the organics were washed with water three times and dried over magnesium
sulfate. Then, the CHCl 3 solvent was removed on the rotary evaporator to afford product (18.5
g; 0.1 mol; 100% yield). The product (6) was vacuum dried in the hood prior to use in order to
remove excess solvent and stored with a piece of CaH 2 .
8. Coupling of Boc-L-proline and L-proline methyl ester
O

EDCI/HOBT

+

N
Boc

CO 2H

(8)

Et 3N/CHCl 3

NH
CO 2Me

(9)

RT, overnight

N
N
Boc MeO C
2

(10)

0.595 g (2.8 mmol) of Boc-L-proline (8) was dissolved in15 mL of CHCl 3 in a 250 mL round
bottom flask. To this solution, 0.538 g (2.8 mmol) of EDCI and 0.43 g (2.8 mmol) of HOBT
were added. The suspension was stirred for 10 min. 0.463 g (2.8 mmol) of L-proline methyl
ester (9) were dissolved in 3 mL Et 3 N/ 10 mL CHCl 3 and then added to the reaction mixture.
The mixture was stirred overnight. Afterwards, all solvents were removed with the use of a
rotovap. Then, 100 mL of ethyl acetate was added and the mixture was stirred. The solid
residues were removed by gravity filtration. The solution was then washed twice with 50 mL
10% citric acid and four times with 25 mL of 10% NaHCO 3 solution. The extracted product
(10) was dried over Na 2 SO 4 and the solvents were removed in vacuo to obtain a pale yellow oil.
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9. Coupling of Boc-L-proline and L-proline methyl ester
O

EDCI/HOBT

+

N
Boc

CO 2Me

CO 2H

(8)

N

Et 3N/CHCl 3

NH

N

RT, overnight

Boc MeO C
2

(9)

(10)

3.225 g (0.015 mol) of Boc-L-proline (8) was dissolved in 30 mL of CHCl 3 in a 250 mL round
bottom flask. To this solution, 2.325 g (0.015 mol) of EDCI and 2.027 g (0.015 mol) of HOBT
were added. The suspension was stirred for 10 min. 1.903 g (0.015 mol) of L-proline methyl
ester (9) were dissolved in 3 mL Et 3 N/ 10 mL CHCl 3 and then added to the reaction mixture.
The mixture was stirred overnight. Afterwards, all solvents were removed with the use of a
rotovap. Then, 100 mL of ethyl acetate was added and the mixture was stirred. The solid
residues were removed by gravity filtration. The solution was then washed twice with 50 mL
10% citric acid and four times with 25 mL of 10% NaHCO 3 solution. The extracted product
(10) was dried over Na 2 SO 4 and the solvents were removed in vacuo to obtain a pale yellow oil.
10. Synthesis of N-Boc-piperidine
(Boc)2O (0.1 mol)
N
H

(5)

CHCl 3

N
Boc

(6)

To a 250 mL round bottom flask, 100 mL of CHCl 3 and 21.8 g (0.1 mol) of t-Butoxycarbonate
were added. 14.8 mL (0.15 mol) of piperidine (5) were added to the round bottom flask that was
attached to the addition funnel. The solution was then added dropwise over three hours while
stirring. Afterwards, the organics were washed with water three times and dried over magnesium
sulfate. Then, the CHCl 3 solvent was removed on the rotary evaporator to afford product (18.5
g; 0.1 mol; 100% yield). The product (6) was vacuum dried in the hood prior to use in order to
remove excess solvent and stored with a piece of CaH 2 .
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11. Synthesis of 2-(trimethylsilyl)-N-Boc-piperidine
secBuLi (0.03 mol)
TMEDA (0.03 mol)

Bu3SnCl (0.03 mol)

50 mL ether

N

N

0

-80 C
3 hrs

Boc

0

N

Li -80 C -> rt, overnight

Boc

Boc

(6)

SiMe3

(2)

(7)

A 250 mL round bottom flask was dried in the oven and then cooled in the desiccator to remove
all moisture. A septum was put on top of the cooled flask. Through the septum, 100 mL ether,
3.8 mL (0.02 mol) of N-Boc-piperidine (6), and 9 mL (0.06 mol) of TMEDA were added by
syringe. The reaction flask was cooled to -80 0C under argon pressure. 42 mL (0.06 mol) of secBuLi was added slowly to the side of the flask. The reaction was left stirring at this temperature
for three hours. 7.6 mL (0.06 mol) of Me 3 SiCl was slowly added to the reaction, which was then
allowed to come to room temperature overnight. Afterwards, 100 mL of 10% KF solution was
added to the reaction to dissolve the precipitate of LiCl. The organics were washed with 100 mL
of ether, dried over magnesium sulfate, and the solvent was removed on the rotary evaporator.
The product (7) was purified by column chromatography with 98% hexanes: 2% ethyl acetate as
the mobile phase.
12. Synthesis of (S,S)-Val-pro
CH3

H3C
H3C

N

Boc

CO 2H
(11)

+

HN

EDCI/HOBT

Et 3N/CHCl 3 H3C

MeO 2C

CH3

H3C

RT, ON

Boc

(12)

N

N

LiAlH4/THF

H3C
H3C

N

CO 2Me

O
(13)

reflux, ON

CH3
N
CH2OH

CH3
(14)

a.

Synthesis of (13)
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3.47 g (0.015 mol) N-Boc-valine (11) was dissolved in 30 mL CHCl 3 in a 250 mL round bottom
flask. 2.86 g (0.015 mol) of EDCI and 2.03 g (0.015 mol) of HOBT were added to the reaction
flask and the suspension was stirred for 10 min. 1.94 g (0.015 mol) of L-proline methyl ester
(12) was dissolved in 3 mL Et 3 N/10 mL CHCl 3 . The solution was added to the reaction flask.
The reaction was stirred overnight. Afterwards, the solvents were removed with the rotovap to
obtain a pale yellow color. 150 mL of ethyl acetate were added and the mixture was stirred. The
product was gravity filtered to remove solvents. The solution was washed twice with 50 mL of
10% citric acid, and then four times with 25 mL 10% NaHCO 3 . It was then dried over solid
Na 2 SO 4 and the solvents were removed in vacuo to obtain a white solid.
b.

Reduction of (13)

2.0 g of LiAlH 4 were cooled in 15 mL of THF in a 100 mL round bottom flask to –5 C using the
cooling unit. The amide (13) was dissolved in 20 mL THF and slowly added dropwise to the
stirred suspension. The mixture was stirred for 10 min at rt, and then heated at reflux overnight
in an oil bath. Afterwards, the mixture was cooled to rt and then to –5 C. Slowly, 50 mL of 2M
NaOH were added to the reaction via a dropping funnel making sure that the flasks did not touch
to allow for escape of gases. The reaction was gravity filtered with a Buchner funnel to remove
the solid which was then washed with 100 mL of ether. The wash and the filtrate were combined
and extracted twice with 100 mL ether. The ether layer was concentrated to 50 mL in vacuo.
The product was extracted twice with 100 mL 2M HCl. The protonated amine became soluble in
the aqueous layer which was washed with ether. The solution was basified with 50% KOH via a
dropping funnel until pH 14 was obtained and the solution turned cloudy. It was extracted twice
with 50 mL ether and the solvents were removed in vacuo.

Results and Discussion
The N-Boc-piperidine (6) and the silane compound (7) were characterized by GC-MS
while the stannanes were characterized by 119Sn NMR. The peptide compounds were analyzed
by 13C NMR. These analytical techniques proved that the desired compounds detailed above
were successfully synthesized. Chemical purity is very important for the next steps of the
research which are the kinetic and thermodynamic studies. It was made sure that there was no
moisture stored with any of the products.
The GC-MS results showed that (6) was successfully generated: 6.373 min [M+] 185
m/z. Also, the GC-MS proved that (7) was synthesiszed: 11.024 min [M+71]+ 258 m/z.
The 13C NMR results showed that (10) was successfully generated. 13C NMR (C 6 D 6 , δ):
173, 172, 155, 79, 59, 58, 51, 46, 45, 29, 28, 25, 24, and 23. The 13C NMR also proved that (13)
was also successfully synthesized. 13C NMR (C 6 D 6 , δ): 73 (CH), 68 (CH 2 ), 64 (CH), 59 (CH 2 ),
54 (CH 2 ), 40 (CH 3 ), 30 (CH 2 ), 25 (CH 2 ), 24 (CH), and 23 (CH 3 ).
The 119Sn NMR showed that the stannane (1) was successfully synthesized. 119Sn NMR:
δ 155 (C 4 ), 79 (C 4 ), 45 (CH 2 ), 38 (CH), 32 (CH 2 ), 31 (CH 2 ), 30 (CH 2 ), 29 (CH 3 ), 28 (CH 2 ), 21
(CH 2 ), 13 (CH 3 ), and 12 (CH 2 ).
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Conclusion
The synthesis of the desired chiral compounds needed for the kinetic and thermodynamic
resolution studies is an essential part of the research project. Great attention to the purity of each
sample must be taken in order to obtain positive results. The generation of a large amount of the
piperidine-based stannanes and silanes has been mostly successful over the summer. Products
were purified and isolated from excess starting material and other compounds. These
compounds were then ready to pass on to the next phase of the research.
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Designing Fibroblast Growth Factor with Higher Heparin Binding Affinity
Ivy Fitzgerald, D. Rajalingam and T.K.S. Kumar*, Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas 72701
SOS Binding Affinity

Stability Monitored by Limited Proteolytic Digestion
A

M1 2 3 4 5 6 7 8 9

Studies indicate that FGFs produce biological responses by binding to two types of receptors on the
cell surface. The first class is a high affinity family of transmembrane tyrosine kinase receptors
called FGFRs. The binding of FGFs to the tyrosine kinase receptors plays an essential role in
biological activation of FGFs. The prototype FGFR structure consists of an extracellular region, a
transmembrane helix domain, and an intracellular tyrosine kinase domain. Binding of FGF to FGFR
leads to receptor dimerization and subsequent tyrosine autophosphorylation and phosphorylation of
target molecules, which initiates a phosphorylation cascade within the cell that culminates in
multiple cellular outcomes.

Structure of hFGF-1 Depicting the Heparin-Binding Pocket
hFGF-1

- KKNGSCKRG - - PRTHYGQKAIL-

hFGF-2

-KRTGQYKLG - - SKTGPGQKAIL-

hFGF-3

-NGKGRPRRG - - FKTRRTQKSSL-NKRGKAKRG - - PRVKP-QHIST-

hFGF-6

-SKYGRVKRG - - SKVSPIMTVT-

hFGF-7

-NQKGIPVRG - - KKTKKEQKTA-

hFGF-8

-TRKGRPRKG - - SKTRQHQREV

hFGF-9

-NKDGTPREG - - TRTKRHQKFT-

hFGF-10

-NGKGAPRRG - - QKTRRKNTSA-

hFGF-11

-DKEGQVMKG - - NRVKKTKAAA-

hFGF-12

-NKEGQIMKG - - NHVKKNKPAA-

hFGF-13

-NKEGEIMKG - - NHVKKNKPAA-

hFGF-14

-NKEGQAMKG - - NRVKKTKPAA-

hFGF-15

-FHRSFFETGD - - LRSK - - - - - -

hFGF-16

-TRQGRPRQA - - SRSRQNQREA
-TKKGRPRKG - - TRENQQDVHF

hFGF-19

-SSAKQRQLY - - RGFLPLSHEFL

hFGF-20

-SNIYKHGDT - - RYFYALNKDG

hFGF-21

-HRDPAPRGP - - ARFLPLPGLPPA

hFGF-22

-GRTNYHLSA - - HFLPVLVS - - - -

hFGF-23
-PYSQFLSRR - - IPLIHFNTPIPRRH
MolMol representation of hFGF-1. Putative heparin binding site(s) are
shown in green. The heparin binding region is mostly located in beta Amino acid sequence of the predicted heparin binding
strand XI, the loop between strands X and XI and the loop between pocket in various isoforms of hFGFs. Mutations
designed in hFGF-1 are indicated in red.
strands XI and XII.

Methods
 Single point mutations were introduced by QuikChange XL Site-Directed
Mutagenesis Kit from Stratagene.
Double point mutation was introduced by overlap extension.
Wild type, N128K, Y139K, Q141K, and N128K/Y139K mutants of hFGF-1
were purified by heparin-affinity chromatography.
 Thermal, urea, and guanidine hydrochloride denaturation experiments of
wild type hFGF-1 and the designed mutants were monitored by steady-state
fluorescence.
 Differential scanning calorimetric experiments were performed using a
Nano III DSC (Calorimetry Sciences Corp.)
 Heparin/SOS binding affinity experiments were carried out using a VPIsothermal titration calorimetric instrument.
 Limited trypsin digestion of wild type and mutants of hFGF-1 were
monitored using SDS-PAGE gel electrophoresis.
 SOS binding site(s) were characterized using 2D hetero-nuclear NMR
spectroscopy.

40
FGF-1-WT

20

0

N128K/Y139K +SOS

A

FGF-1-WT+SOS
N128K/Y139K

0

50

100
Time in minutes

150

200

Panel A- 1H-15N HSQC spectra of wild type
hFGF-1 obtained in the absence (red) and
presence (green) of SOS. The significant
chemical shift perturbation observed in the
presence of SOS indicates that these residues
are in the vicinity of the SOS site(s). Panel BOverlap of the 1H-15N HSQC spectra of
N128K/Y139K double mutant (yellow) and wild
type hFGF-1 (red).

B

Stability Monitored by DSC

1.4

-NKDGSPREG - - YRTKRHQKFT

hFGF-17
hFGF-18

60

Identification of SOS Binding Site(s) on hFGF-1

Weighted Average chemical shift
perturbation (ppm)

N128

ITC curves showing the binding of SOS/heparin to wild type and mutants of hFGF-1 at 25 C. The
upper panels show the raw data representing hFGF-1 – SOS titration. The bottom panels show the
integrated data obtained from the raw data after background subtraction. The solid line in the
bottom panels represent the best-fit curve of the experimental data, using the one site and sequential
binding site(s) model from Microcal Origin.

-SKNGKTKKG - - NRVSPTMKVT-

hFGF-5

80

Time-dependent trypsin digestion of the wild type and N128K/Y139K double mutant of
hFGF-1 in absence and presence of SOS. Lanes 1 through 9 represent the trypsin digestion
products formed after 0 min (lane 1), 15 min (lane 2), 30 min (lane 3), 45 min (lane 4), 60 min
(lane 5), 90 min (lane 6), 120 min (lane 7), 150 min (lane 8) and 180 min (lane 9). Panel B
represents the densitometry scan of the band corresponding to hFGF-1 wild type and the
N128K/Y139K mutant band (~16 kDa). The concentration of the protein and SOS used were
0.05 mM and 0.5 mM, respectively.

123 to 142

1.2

1H-15N

chemical shift perturbation of residues in
hFGF-1 in the presence of SOS. The amino acid
residues in hFGF-1 that exhibited significant
chemical shift perturbation and are involved in SOS
binding are indicated by the residue number.

1
0.8
0.6
0.4

87

0.2
0

22

42

62

82

102

122

142

Amino Acid Residue Number

Differential scanning calorimetry thermograms representing the unfolding of wild type and mutants
of hFGF-1. The protein (0.5 mg/mL) was dissolved in 10 mM phosphate buffer (pH 7.2) containing
100 mM NaCl and 50 mM ammonium sulfate. Thermograms were corrected for background noise.
The experiments were performed at a scan rate of 1 C/min.

MolMol representation of the structure of hFGF-1
(Blue). Residues which exhibit prominent chemicalshift perturbation are indicated in green. The
residues constituting the SOS binding site(s) are
mostly located in beta strand XI and the loops
between strands X and XI and strands XI and XII.

Stability Monitored by Fluorescence Spectroscopy
A

B

1
0.8

FGF-1-WT- Tm= 44.7 C
FGF-1-WT+SOS- Tm= 50.1 C
N128K/Y139K- Tm= 42.6 C
N128K/Y139K+SOS-Tm= 53.8 C

C

1

0.8

0.6
0.4

Fraction unfolded

Q141

100

N128K/Y139K+SOS

Fraction unfolded

hFGF-4

N128K/Y139K

WT+SOS

Fraction unfolded

Y139

WT

B

-

The second class of receptors is the family of heparan sulfate proteoglycans (HSPGs), which have a
low affinity for FGFs. HSPGs are polymers of disaccharide repeats, which are highly sulfated and
negatively charged. HSPGs are found in the extracellular matrix adjacent to cell surfaces and as
integral components of the plasma membrane. The absence of HSPGs on cell surfaces reduces FGF
oligomerization, which affects FGF binding to FGFR(s) and lowers FGFR activity. The interaction
of heparin with FGFs stabilizes the protein against thermal denaturation, proteolysis, FGF release
into interstitial spaces and limits diffusion. Binding also increases mitogenesis and wound healing.
Additionally, heparin helps to increase the affinity and half-life of the FGF-FGFR complex, which
is crucial for signal transduction. Sucrose octasulfate (SOS) is a heparin analog that has been shown
to mimic heparin action and FGF activation. Residues involved in heparin binding correspond to
amino acids 126 to 142 of the human FGF-1 sequence. In this context, we examined the structural
and functional consequences of insertion of additional lysine residues in the heparin binding pocket.
The results clearly indicate that the introduction of lysine residues at positions N128, Y139 and
Q141 in the heparin-binding pocket significantly increases affinity to sucrose octasulfate.

M1 2 3 4 5 6 7 8 9

Band intensity (arbitrary units)

Background
Fibroblast Growth Factors (FGFs) play a significant roles in the regulation of cell proliferation,
angiogenesis, differentiation, tumor formation, embryonic growth, invasion, inflammation, and
tissue repair. To date, at least 23 FGFs have been discovered, named consecutively from FGF-1 to
FGF-23. FGFs are about 154 amino acids long and share a common core of 140 amino acids, of
which 28 residues are highly conserved and 6 residues are invariant. FGFs are all beta-barrel
proteins and contain no disulfide bonds.
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Conclusions

 Several hFGF-1 mutants with additional lysine residues in the heparin binding pocket have
been successfully generated, expressed and purified.

0.6

 Incorporation of additional lysine residues increases the heparin-binding affinity of hFGF-1.

0.4
0.2
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FGF-1-WT- Cm= 2.38

N128K/Y139K- Cm= 2.40

0.05

5

0

0.05 M
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0

1
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4
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 The thermodynamic stability of the double mutant (N128K/Y139K) of hFGF-1 increases
significantly upon binding to SOS.

0.05 M

FGF-1-WT+SOS- Cm= 3.40

0.05 M

N128K/Y139K+SOS-Cm= 1.85

0

1

0.8

6

0.05

7

Concentration of urea [M]

Panels A, B, and C represent the equilibrium unfolding of the wild type hFGF-1 and the
N128K/Y139K double mutant of hFGF-1 in absence and presence of SOS, induced by thermal,
guanidine hydrochloride, and urea, respectively. The denaturation were monitored by steady-state
fluorescence at 350 nm. The binding of SOS provides additional stability to the double mutant as
compared to the wild type hFGF-1.

 The backbone conformation of the double mutant is similar to wild type hFGF-1.
 SOS appears to bind to the positively charged residues in the heparin binding pocket.
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The Enhancement of In Vitro Microdialysis Recovery of
Interferon-γ Using Affinity Agents
Hill College, 2University of Arkansas, Department of Chemistry and Biochemistry

Microdialysis is a common way to sample small, low molecular weight
analytes. In living tissue it has become increasingly important to study small
signaling proteins called cytokines. These proteins are vital for cellular
communication. In vivo, a small microdialysis probe is inserted into the
tissue. A buffer solution is perfused through the probe and cytokines diffuse
through the membrane. The cytokines are collected though the outlet tube
(Figure 1).

Inlet

Outlet

Figure 1: Schematic of

Figure 2: 3D structure of

microdialysis probe

Interferon-γ, ~15.9 kDa.

One specific cytokine of interest is Interferon-γ (IFN-γ) (Figure 2).
Interferons are naturally occurring proteins produced by cells of the immune
system in response to foreign agents, such as viruses. Specifically, IFN-γ
activates natural killer cells and macrophages, up-regulates antigen presence
in lymphocytes, and induces resistance of host cells to viral infection.
One issue that arises with cytokine microdialysis is a general low
relative recovery. This is due to several factors including, size and
conformation of the cytokine, interactions between the cytokine and the
probe, and flow rate of the perfusion fluid. Affinity agents can increase
cytokine recovery by changing the concentration gradient (Figure 3).
Heparin, a naturally occurring glycosaminoglycan, is negatively charged and
can bind several common cytokines (Figure 4). Recent studies have shown
an increase in relative recovery with perfusion fluid containing heparin.
Cytokine antibodies have also been used to increase relative recovery.
WITHOUT Affinity Agent

Buffer

Microdialysis
• For all microdialysis experiments the CMA/20 (10mm) Polyethersulfone (PES) probes with 100kDa
cut off were used.
• The probes were connected to CMA402 syringe pumps with 1000μL syringes.
•The buffer for all experiments was the ELISA kit buffer (PBS with 10% FBS, pH 7.0).
•The probes were immersed in a sample fluid containing 2000 pg/mL IFN-γ.
• A control was run simultaneously, containing only assay diluent.
• Heparin Sodium Salt was purchased from Sigma-Aldrich.
• For the Heparin experiments, flow rates of 2μL/min and 1μL/min were used. The perfusion fluid
contained 10μM Heparin.
• For the antibody experiments the ELISA biotinylated anti-rat monoclonal detection antibody was used
in the perfusion fluid (1.6 nM). A flow rate of 1μL/min was used.
ELISA
•Samples were analyzed using the Rat IFN-γ ELISA kit (BD Biosciences).
•Rat IFN-γ standards from the ELISA kit were used in all experiments.
•The samples were analyzed with a Tecan Infinite M200 multifunctional microplate reader.
•Fluorescent absorbance (Figure 5) was measured at 450nm and subtracted at 570nm.
•The Heparin experiment samples were analyzed according to the ELISA protocol by BD Pharmigen.
• The detection antibody samples were analyzed using a modified ELISA procedure. In the modified
procedure the cytokine samples were prepared and incubated with detection antibody before being
added to the microwells as opposed to the standard protocol, which requires addition of the antibody
after the samples have incubated in the microwells.
•Both affinity agents were tested for interference with the ELISA procedure.

~ 1μL/min
Flow rate

Perfusate

Heparin Samples
Different concentrations of Heparin were added to standard IFN-γ to test for
interference with the ELISA assay. Heparin concentrations up to 10μM do not interfere
with the assay (Figure 6). Microdialysis samples with heparin in the perfusion fluid
were collected at two flow rates and analyzed (Figure 7). As expected the microdialysis
yielded a small relative recovery. The heparin added to the perfusion fluid did not
appear to increase RR. This may be due to the binding kinetics of heparin and IFN-γ
Detection Antibody Samples
Detection antibody was also incubated with IFN-γ to test for interference with the
ELISA assay. Only the twelve hour incubation time appeared to affect the assay (Figure
8). Microdialysis samples with antibody in the perfusion fluid were collected and
analyzed (Figure 9). For the shorter collection time, the antibody sample did not have
enough cytokine to show absorbance. The antibody control yielded a similar recovery
to the heparin control. At the four hour collection time, the antibody sample did
increase RR, but not significantly.
Log-Log of IFN-γ with Heparin
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0.80%

1.23%

-1.1

-1.6

Length 1-30mm

Perfusate

WITH Affinity Agent

IFN-γ

This project aims to study the relative recovery of Interferon-γ using microdialysis. To this
end, two known affinity agents, heparin sulfate and the detection antibody for IFN-γ, were
used to increase the flow of cytokine into the microdialysis probe. Dialysate samples were
collected and analyzed by fluorescent absorbance.

MATERIALS AND METHODS

Semipermeable
Membrane

RESULTS

OBJECTIVE

Absorbance (nm)

INTRODUCTION

Absorbance (nm)

1Spring

Chris Ladner1, Julie A. Stenken2

Figure 9
Concentration (pg/mL)

Figure 8

Dialysate

o.d.
200-500 μM

CONCLUSIONS
Interferon-γ microdialysis samples were successfully collected using affinity agents.
Both heparin and the detection antibody do not appear to interference with the ELISA
procedure, which is used to analyze the samples. Though they do not interfere, the
affinity agents do not appear to significantly increase the relative recovery of the IFN-γ.
Interestingly, the modified ELISA procedure is a viable way to collect and analyze
cytokines. In future work different cytokines may be tested with these procedures.

Dialysate

Figure 3: The affect of affinity

agents in the microdialysis probe.

Acknowledgements
Figure 4: Chemical and 3D
structure of heparin.

Figure 5: Diagram of ELISA (EnzymeLinked ImmunoSorbent Assay) procedure.
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Exploratory Hierarchical Nanomachining of New ZnO Tertiary Hetero-Nanostructures
Sean Nomoto, Andrew Zhou, Z. R. Tian
REU, Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701

Results

Motivation
•Tertiary Synthesis of nanobranches on
secondary nano-branches of ~5 microns in
length;
•High concentrations of the diaminoalkane, 1, 3propanediamine, were used in Tertiary synthesis

Introduction
• ZnO nanostructures have been extensively
studied because of their unique properties
including a wide band-gap of 3.37eV1,
photocatalysis, emission and absorption of light,
etc.
• Many ZnO nanostructures have been
synthesized by reacting
hexamethylenetetramine (HMT) with zinc nitrate
in water via the mechanism shown below in
equations (1)-(4)2.

Synthetic Reactions of HMT and Zn(NO3)2

Conclusion

•Rich chemistries involved in the tertiary growth with DAP, most of which are not well understood
especially at high DAP-concentrations ;
•More work on trends such as time, of reaction, temperature, etc. are needed;
•These structures may have physical properties worth studying, such as piezoelectricity and
photocatalytic capabilities
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Experimental Procedure
• Primary rods were made with HMT, Zn(NO3)3
• Secondary branches made with same materials as Primary rods with DAP added
• Tertiary structures made by changing amounts of DAP
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Preliminary Characterization of the Binding of Peptide Derivative of an Important Ras
GTPase Binding Effector for Abnormal Cell Signaling Mutants of the Ras Protein Cdc42
Nikita Patton, Huimin Liu PhD, Paul Adams, PhD
University of Arkansas at Fayetteville

Cell division cycle (Cdc42) is a GTPase protein in the Ras Superfamily. Ras
proteins are responsible for regulating cell growth and cytoskeleton organization
and Ras mutants are likely to be found in many different cancer type cells. Cdc42GTP is the active state (GTP), Cdc42-GDP is its inactive state. When the Cdc42
begins to act in an overactive state, this leads to cell transformation. p21
activated kinase (PAK) is one an effector protein that interacts with Cdc42. Forty
six amino acids of PAK known as Protein Binding Domain 46 (PBD46) interacts
with Cdc42 to control its intake of GTP. PBD46 contains the CRIB binding domain
which is about 12 essential amino acids that directly interact with Cdc42. When a
mutation occurs in Cdc42 at position 28 where the phenylalanine amino acid is
changed to leucine, the GTP/GDP cycle is more rapid which leads to cell
transformation. This leads to cancer. This mutation is known as F28L. The
structure of F28L is known but its binding complex is not. Another mutation is
referred to as ∆L8. This mutation is when the Rho insert region, amino acids 120
to 133, have been deleted from the protein‘s amino acid sequence. ∆L8 still
allows spontaneous GTP/GDP exchange of the protein, but does not result in
cellular transformation. Currently, the structure and function of ∆L8 is unknown.
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47.5
32.5

MW

Protein Expression

•Start overnight culture in an incubator at 37˚C.
•Inoculate 1% of overnight culture in LB media.
•Cell growth and cell density (Optical Density) was checked using a UV
spectroscopy at 600nm, reading between 0.6-0.8.
•Induce with 1mM IPTG
•Harvest was done with centrifuge.
•Expression was confirmed by Western Blot (WB).
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1ees.pdb
Giazchew D, Oswald RE.
Biochemistry 39: 3963-3971

25

6.5

In Vitro Binding Assay

Cdc42- PBD46 complex

Adams, PD

RESULTS

METHODS

INTRODUCTION

The purpose of this is to determine if Cdc42 mutants F28L and ∆L8 bind
to PBD46 relative to Cdc42 WT.
•The cell lysate of Cdc42 WT, F28L, and ∆L8 were each tested binding to
purified PBD46.
•GST was used as nonspecific binding controls with Cdc42 WT, F28L, and
∆L8.
•Mix samples in PBS buffer and 0.5mM GMPPCP was applied.
•Incubated at 4°C for 4 hrs.
•Add glutathione sepharose beads and incubate at 4°C for 1hr .
•Beads were washed with PBS buffer
•Elute with 20mM Tris 10mM glutathione buffer pH8.
•Run SDS-PAGE to visualize the quantity of PBD46 and GST being
recovered from the process.
•Perform WB. Detect Cdc42 WT and mutants by adding the first
antibody N-terminus-His tag that binds to the His-tag and the
secondary antibody goat anti-mouse IgG-AP.
•Develop membrane using the enzymatic reaction of BCIP and NBT in
TBS-MgCl2 buffer. 10% Acetic acid was used to stop the reaction once
all the protein is visible on membrane.

16.5
6.5

•Figure 1 part A shows good expression levels of the Cdc42 WT and mutants.
•Figure 1 part B shows that expression of a protein is very sensitive to initiation
of induction. If exponential growth is very high, then the protein expression is
lower.
•Figure 2 verifies which bands on the gel were our proteins of interest.
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Figure 3 shows that in the In vitro binding
assay, Cdc42 WT and mutants does bind to
PBD46 and not GST tag.

CONCLUSIONS

F28L

The In Vitro Binding assay showed
qualitative data that Cdc42 WT and
mutants does bind to PBD46 and not
GST tag.
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FUTURE WORK
•Optimize the expression of mutants.
•Quantify the binding parameters of
PBD46 to each Cdc42 mutant
compared to the wildtype.

Analysis of Methionine Sulfoxide from Urinary Proteins in Relation to Tobacco Use
Ashley Ramsey*, Dr. Jeff Froude, and Dr. Wesley Stites
Department of Chemistry and Biochemistry
University of Arkansas, Fayetteville, AR 72701

Introduction

Proteins are sensitive to oxidative damage and
the biological effects are usually very important.
Protein oxidation is proposed to contribute to
the aging process because they are found to be
increased in older organisms. Methionine is one
of the easiest residues to oxidize even though it
is not very common. The oxidation of
methionine occurs in a wide variety of proteins.
The oxidants found in biological systems, ozone,
and cigarette smoke all have been shown to
oxidize methionine in proteins and peptides. This
oxidation tends to lower or even stop the
biological activity.

Summary

These chromatograms represent how the
peaks were determined. The samples
were spiked with the amino acid of choice
and analyzed in the HPLC.

In the urine studies, the amount of methionine
sulfoxide is noticeably more in the smokers than in
the non smokers.(results not shown) This is what
we were expecting to find. One thing that is not as
we expected, is the fact that the amount of
methionine is not decreasing proportionately with
the increase of methionine sulfoxide. We have not
yet figured out how this is possible. These results
show us a general increase in methionine sulfoxide
in our test cases.

Oxidative stress in general is linked to the
increased tendency to coagulate, although the
molecular mechanism is not yet completely clear.
The blood of smokers is much more prone to
clot than that of non-smokers. Cardiovascular
diseases are the most common cause of
premature death in smokers. The most common
cardiovascular diseases in smokers are the
thrombotic arterial occlusive diseases, in
particular myocardial infarction (heart attack)
and stroke.

Purpose

To determine an analytical method to measure
the amount of methionine sulfoxide in complex
protein mixtures such as urine and liver.

Future Work

These chromatograms are of samples from a rat liver. The first shows the control, then a sample that was taken 2 hours after an
injection of acetaminophen, and then 4 hours after the injection. The second chromatogram shows that the amount of methionine
sulfoxide increases in the liver after 2 hours and even more after 4 hours. The last chromatogram shows that the amount of methionine
in the samples.

Methods

The procedure was the same for the urine and
the rat liver. The only difference is that the urine
started with spinning down in a centrifuge. The
pellet was then re-suspended in methanesulfonic
acid (MSA) and put into a hydrolysis tube. For
the rat liver, the liver was thawed and weighed
out. It was then put into a hydrolysis tube with
MSA and a freeze-pump-thaw method was used
to remove the gasses. The tube was then put
into a heat block for 2 hours. Afterwards, the
sample was diluted with water and ran through
an ion exchange column. Five micro liters of the
eluted sample was lyophilized dried, derivatized,
and reconstituted in a diluent. This was then
analyzed in the HPLC.

A method was determined to measure the amount
of methionine sulfoxide in urine and liver.
In the rat liver, the amount of methionine sulfoxide
is being increased as the time is passed after the
overdose of acetaminophen. We know that the peak
is methionine sulfoxide but we are not sure if
something else is there also. If it is something else
with the methionine sulfoxide, the increase in
acetaminophen is affecting it. Future tests will be
done to determine what else is there.

In the future, the Stites Research group will be
continuing this work on both the rat livers and the
urine. They are working on the oxidation of
thrombomodulin and a method to measure it more
quickly. They are also interested in using the
method determined here and taking it further to
increase the productivity. The group will also be
testing this method on a number of smokers and
nonsmokers urine samples to get more conclusive
results. Once we know how oxidative stress effects
the body, researchers will be able to design drugs
that will help reduce the stress or maybe even
prevent it.
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For the graphs, a ratio was taken for the peak of interest against a peak that was an internal standard. The levels the methionine
sulfoxide were higher in the 2 hour and 4 hour than in the control. The level of methionine was close in the 2 hour and lower in the 4
hour. The last graph shows that the relative amount of methionine sulfoxide was higher than the methionine in the 2 hour and 4 hour
than in the control.
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Development of Polyeugenol Coated Electrodes for Chemical Sensors
Michelle Reed* and Dr. David Paul
Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville AR, 72701

Introduction

•Brain tissue oxygen monitoring is an
important area of research.
•A major problem with electrochemical
detection in vivo is chemical fouling due to
cerebrospinal fluid.1
•Nafion® is an oxygen-permeable polymer
commonly used to coat electrodes to
prevent fouling.
•The Nafion® polymer coating is easy to
apply, but covers the entire electrode and
creates a “trapped” oxygen effect.
•In this work, the performance of an
electropolymerized eugenol film will be
compared to Nafion® for oxygen detection.

Purpose

Structure of Eugenol

•Determine if eugenol can
be electropolymerized on
gold to form an even
coating.
•Compare the performance
of polyeugenol coating to
that of Nafion®.

Methods

Data and Results
Exclusion of RuHex by Electropolymerized Eugenol

Polyeugenol Formation3

•2 mm gold disk electrodes.
•10 mM eugenol in 0.10 M NaOH.
•Cyclic voltammetry (CV), 20 cycles
between 0.7 V and 0.0 V vs. SCE at 0.1 V/s.

O2

O2

•Cyclic voltammetry from 0.2 to
-0.5 V vs SCE at 0.02 V/s.
•10 mM ruthenium(III) hexamine
(RuHex) in 0.1 M KCl.

Bare Gold
No RCA-1 Cleaning
With RCA-1 Cleaning

If prepared correctly, eugenol
films were impervious to large
molecules.

Analysis of Dissolved Oxygen (DO)
0.25 mg/L
1.00 mg/L
2.00 mg/L
3.00 mg/L

4.13 mg/L
5.00 mg/L
6.00 mg/L
6.30 mg/L

•Chronoamperometry from 0.0 V
to -1.0 V step vs SCE; 15 s pulse
width.
•Various dissolved oxygen
concentrations in 0.1 M KCl.
•Eugenol-coated electrodes (at
left) and Nafion-coated electrodes
(not shown).
•Current measured at 14 s after
step.

Dissolved Oxygen Calibration Curves
Data indicates that at 14 s the
calibration curve using
Nafion® is non-linear, while
eugenol is linear.
6 µm Nafion
Eugenol

Oxygen once “trapped” in the
Nafion® membrane is able to
diffuse to the electrode.
Higher DO concentrations
and shorter times enhance
the effect of the “trapped”
oxygen.

O2

Endogenous

Endogenous

Trapped
O2

Gold Surface

Nafion® Coating

RCA-1 Cleaning2

•27% ammonium hydroxide, 30% hydrogen
peroxide, and water.
•Cleaned electrode at 70°C for 15 min., then
rinsed with water and air-dried.

Electrode Coating

Electrode insulator

Polyeugenol Coating

Conclusions
•Eugenol can be electropolymerized onto
a gold electrode evenly after a RCA-1
cleaning.
•A uniform eugenol coating is
impermeable to large molecules such as
RuHex.
•Eugenol produces a linear DO calibration
curve from 0.2 to 6.0 mg/L.
•The DO calibration curve using Nafion® is
non-linear above 2.0 mg/L.
•Eugenol is a better polymer for coating
electrodes because it electropolymerizes
only on the gold surface, eliminating
oxygen “trapped” in the membrane.
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Analysis of Plasma Polymerized Acetylene Films on Silicon Chips by Fourier Transform Mass Spectrometry
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Results Continued

Introduction
Fourier transform mass spectrometry has been
used to identify the products formed by plasma
polymerization of acetylene on silicon chips.
Three chips are analyzed here. Each chip was
formed using a different discharge method, one
with unipolar, one with bipolar, and the last one
with continuous discharge. Both positive and
negative laser desorption/ionization-Fourier
transform mass spectrometry spectra were
collected. The analysis indicates a difference in
the acetylene products of each film.

LDI-FTMS of Unipolar Discharge Film

LDI-FTMS of Bipolar Discharge Film

LDI-FTMS of Continuous Discharge Film

Figure 2.LDI-FTMS spectra of Unipolar Discharge Film: Insets show
partial spectrum with assignments of the most abundant peaks
inclding calculated molecular weights and average resolving power.

Figure 3. LDI-FTMS spectra of Bipolar Discharge Film: Insets show
partial spectrum with assignments of the most abundant peaks
including calculated molecular weights and average resolving power.

Figure 4. LDI-FTMS spectra of Continuous Discharge Film: Insets
show partial spectrum with assignments of the most abundant peaks
including calculated molecular weights and average resolving power

Experimental
- External source 9.4 Tesla FTMS IonSpec
- Nd:YAG laser operating at 355 nm
- Samples were placed neat on a stainless steel
target plate
Results
Figure 1: Film Assignments

Conclusion
The results of this analysis show the presence of carbon clusters and hydrocarbon oligomers in different relative abundances. It is
clear from the spectra that the bipolar method of plasma polymerization forms relatively more hydrocarbon oligomers compared to
the products of unipolar and continuous discharge. It can also be seen that if the thickness of the film is increased, this leads to a
broader mass range in the spectrum.
Acknowledgements
Figure 1. Plots of number of hydrogen versus number of carbons in
hydrocarbon oligomers. Spectra that produced only carbon clusters
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Racemization of Chiral Lithium Carbanions: An Exercise in
Organic Synthesis, Analytical Chemistry,
Solution Kinetics, and Chemical Thermodynamics
Andrew L. Ward, Department of Chemistry and Biochemistry, University of Detroit Mercy,
4001 West McNichols Road, Detroit, MI 48221-3038,
wardan@students.udmercy.edu

Kinetics and Thermodynamics

Analytical Techniques

Background
The synthesis of natural products and
pharmaceuticals involves the use of chiral lithium
carbanions since they can be generated using chiral
bases and retain their structural integrity even at low
temperatures. When the lithium carbanion is quenched
with an electrophile, a new chiral center can be generated.
The main goal of our project is to determine the rate at
which the chiral carbanion 2-Li-N-Boc-piperidine (2)
racemizes, both in the presence and absence of diamine
ligands. The carbanion is synthesized by Sn/Li exchange
from the stannane (1).

1. Chromatography
Prior to studying the kinetics of racemization, it is important to be able to separate the two
enantiomers of the silane (7). The traditional way to do this is by Chiral Stationary Phase - Gas
Chromatography [CSP-GC]. A representative CSP-GC chromatogram is shown below in Fig. 6.

To date, the racemization of Fig. 1 has only been studied with TMEDA as shown
below in Fig. 9, at three different temperatures.
2.5

y = -0.0001x + 2.0742
2

R2 = 0.9739

1.5

1

y = -0.0005x + 2.0337
y = -0.0042x +
2.129

0.5

R2 = 0.9598

R2 = 0.998
0
0

500

1000

1500

2000

2500

-0.5

233 K

3000

3500

Reaction Conditions:

Time (s)
223 K

s

BuLi= 1.2 eq; TMEDA= 1.0 eq
C= 0.250 in Et 2O

243 K

Fig. 9. First order plot for the racemization (2)S --> 2(R) in the
presence of one equivalent of TMEDA.

Fig. 6. CSP-GC Chromatogram of Racemic Silane (7)

The rate constants were obtained from the slope of the line at each temperature,
and are tabulated below.

The disadvantages of this technique are:

Temperature (K)

Parameters

1. The very long retention times [ca. 2 hours]
2. The need for sample workup to remove tetrabutyltin prior to injection [Fig. 1].

223 (-50 °C)

243 (-30 °C)

-0.0001
-14.6175

-13.0519

-10.9657

1/T (s-1)

0.004484

0.004292

0.004115

t1/2 (s-1)

6931.5

1386.3

165.0

115.5

23.10

2.7

(min)

The above problems can be solved using Chiral Stationary Phase - Supercritical Fluid
Chromatogrpahy [CSP-SFC]. Both the stannane (1) and the silane (7) can be resolved with this
method. A typical CSP-SFC is shown below in Fig. 7.

233 (-40 °C)

k (s-1)
ln(k/T)

-0.0005

-0.0042

In order to obtain the thermodynamic activation parameters (∆H‡ and ∆S‡ ) we
need to plot lnk vs. 1/T, where T is the absolute temperature in Kelvin. The result
is known as an Eyring plot.
0
-2

Fig. 1. Sn/Li exchange with complexation of ligand to the racemic
organolithium.

-4
-6
-8

y = -9869.6x + 29.539

-10

R2 = 0.9899
-12
-14
-16
0.00405

0.0041

0.00415

0.0042

0.00425

0.0043

0.00435

0.0044

0.00445

0.0045

0.00455

1/T

Fig. 10. Eyring plot of lnk vs. 1/T for the racemization of Fig. 1 in the presence of TMEDA.

Synthesis

(7)

Fig. 2. Synthesis of N
N-Boc-Piperidine
Piperidine

(1)

Fig. 7. CSP-SFC Chromatogram of Racemic Silane (7) and its parent
Stannane (1).

Note that the stannane (1) elutes first even though it has a higher molecular weight. This is
because it is the less polar of the two compounds and the column is polar. The chiral stationary
phase is 4-(3,5-dinitrobenzamido)tetrahydrophenanthrene covalently bonded to silica.
(5)

(6)

2.

Fig. 3. Synthesis of 2-(tributylstannyl)-N-Boc-piperidine (1)

119Sn

NMR Spectroscopy

It is clear from Fig. 1 that complete Sn/Li exchange is an essential prerequisite to any study of
the kinetics of racemization. The Sn/Li exchange of Fig. 1 can be readily followed in situ by 119Sn
NMR spectroscopy, as shown below in Fig. 8.
(1)

(6)

(2)

Bu4Sn

(1)

Bu4Sn

(1)

Bu4Sn

(2)

Conclusion

We are now continuing our studies of the above racemization kinetics, but in
the presence of chiral diamine ligands. The overall objective is to map out
what structural features of both the carbanion and the ligand are necessary
for the most effective dynamic thermodynamic resolution [DTR].
(7)

t=

0

30 min

1 hr

4hr

Fig. 8. Kinetic Study of the Sn/Li exchange of Fig. 1 by 119Sn NMR at -60 °C.
(i-Pr)4Sn as internal standard (at 0 ppm).

Note how broad the Sn signal for the stannane (1) is: this is due to restricted rotation about the N-C
bond of the carbamate group at the low temperature of the reaction.
(9)

Conclusion

The above values are surprisingly low! They afford a reaction barrier of ca. 17
kcal/mol over the temperature range of Fig. 9; this is 2 kcal/mol lower than the
corresponding barrier for N-Boc-pyrrolidine in the presence of TMEDA. It is not
at all clear why this should be the case.

Next Steps

(1)

Fig. 5. Synthesis of (S,S)-Pro-prolinol (10)

(8)

∆H‡ = 19.6 ± 1.4 kcal/mol
∆S‡ = 11.5 ± 6.0 cal/mol*K

(1)

Fig. 4. Synthesis of 2-(trimethylsilyl)-N-Boc-piperidine (7)

(6)

The Enthalpy of Activation (∆H‡ ) for the reaction is obtained from the slope of
the line in the Eyring plot, and the Entropy of Activation (∆S‡) come from the
intercept on the y-axis. The corresponding values are given below:

(10)
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